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Abstract 
 
AMPA receptors are an important class of ionotropic glutamate receptors which participate in fast 
excitatory synaptic transmission in most brain areas. They are tetrameric complexes composed of 
GluR-A, B, C and/or D subunits, and have a pivotal role in adjustment of cell membrane 
excitability as their cell membrane expression level is highly regulated in brain physiology. The 
subunit composition of AMPA receptors is developmentally and transiently regulated and differs 
between brain areas. Further, AMPA receptors have alternatively spliced variants with differences 
in ion channel function, pharmacology and localization of receptors. Recently, AMPA receptor 
trafficking and cellular localization have been found to be regulated by several proteins, such as 
transmembrane AMPA receptor regulatory proteins (TARPs). The interaction of TARPs and 
AMPA receptor subunits is required in normal AMPA receptor function in many, if not all, brain 
areas. 
 NMDA-type glutamate receptors are important target molecules of ethanol. They are 
inhibited by clinically relevant concentrations of ethanol. Whereas, the role of AMPA receptors in 
the actions of ethanol has not been clarified as thoroughly. Furthermore, the regulation of AMPA 
receptor synthesis and their possible adaptation in neurons with altered inhibitory mechanisms are 
poorly understood. In this thesis work AMPA receptor pharmacology, trafficking and synaptic 
localization was studied using patch-clamp electrophysiology. Mechanisms were clarified by 
studying functions of both native and recombinant, wild-type and mutant AMPA receptors in 
isolated neurons and HEK293 cells. In addition, hippocampal slices from transgenic Thy1?6 mouse 
line with altered GABAA receptor-mediated inhibition were used to study adaptation of AMPA 
receptor currents.  
 Ethanol (> 25 mM) was found to inhibit AMPA receptor function by increasing 
desensitization of the receptor, as the steady-state component of the current was inhibited more than 
the peak current. Ethanol inhibition was reduced when cyclothiazide was used to block 
desensitization in native neurons and when non-desensitizing point-mutated GluR-A and GluR-D 
receptors were studied. In GluR-D receptors, ethanol also accelerated the onset of desensitization, 
which was measured as a time constant of peak current decay. The coexpression of TARP-proteins 
stargazin and ?4 increased this effect of ethanol. The results suggest that ethanol inhibits AMPA 
receptors by increasing and accelerating their desensitization. 
We found that the agonist binding capability is a feature of AMPA receptors that is 
important for trafficking them from endoplasmic reticulum to the cell membrane. Stargazin rescues 
the surface expression of non-binding AMPA receptor mutants in HEK293 cells, but not in native 
neurons. The state of synaptic AMPA receptor-mediated function was studied in Thy1?6 mice with 
lowered synaptic GABAA receptor-mediated function. Thy1?6 mice had decreased AMPA 
receptor-mediated function in hippocampal CA1 neurons, measured as reduced mEPSC amplitudes 
as compared to wild-type neurons. These transgenic mice also had lower sensitivity to maximal 
electroshock convulsions, presumably due to the decreased AMPA receptor function. 
 In conclusion, the results suggest that the AMPA receptor may be target for alcohol 
action at least during heavy intoxication, probably through accelerating onset and increasing the 
extent of desensitization. TARPs appear to enhance ethanol inhibition and to participate in 
trafficking of AMPA receptors upon their synthesis in the cell. AMPA receptors mediate also long-
term adaptation to altered neuronal excitability, which adds to their well-known role in synaptic 
plasticity for e.g. in physiology of learning and in pathophysiology of drug addiction.  
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Tiivistelmä 
 
AMPA reseptorit ovat tärkeä glutamaattisten reseptorien luokka, jotka osallistuvat nopeaan 
hermoviestinvälitykseen suurimmassa osassa aivoja. Ne koostuvat neljästä alayksiköstä ja niillä on 
keskeinen asema hermosolujen solukalvon toiminan säätelyssä, mm. synapsien voimakkuuden 
säätämisessä, sillä niitä kuljetetaan jatkuasti solukalvolle ja pois solukalvolta. AMPA reseptorien 
alayksikkökoostumus vaihtelee kehityksen kuluessa ja aivoalueiden välillä. Niillä on lisäksi 
vaihtoehtoisia silmikointimuotoja, jotka eroavat toisistaan ioniläpäisevyydeltään, farmakologialtaan 
ja sijainniltaan. Viime vuosina on löytynyt lisäksi monia AMPA reseptoreita sääteleviä proteiineja 
kuten TARPit (engl. transmembrane AMPA receptor regulatory protein). AMPA reseptoreiden ja 
TARPien välisten vuorovaikutuksien on osoitettu olevan tarpeellisia normaalille AMPA reseptorien 
toiminnalle monilla, ehkä jopa kaikilla, aivoalueilla. 
 Lukuisat tutkimukset ovat osoittaneet, että kliinisesti merkittävät etanolipitoisuudet 
estävät NMDA-tyyppisiä glutamaattireseptoreita. Sen sijaan, etanolit vaikutukset AMPA 
reseptoreihin ei ole yhtä tarkasti tiedossa. Tämän lisäksi huonosti tunnetaan miten estävän 
hermoviestinvälityksen muutokset vaikuttavat AMPA reseptoreiden säätelyyn. Tässä väitöskirjassa 
on tutkittu miten etanoli vaikuttaa AMPA reseptoreihin, miten niitä kuljetetaan solukalvolle sekä 
miten niitä esiintyy synapseissa käyttäen hyväksi patch clamp sähköfysiologiaa. Työssä käytettiin 
sekä aivopreparaatteja että HEK-solu ekspressiosysteemiä, joiden avulla tutkittiin sekä 
villityyppisiä että mutatoituja AMPA reseptoreita. Tämän lisäksi Thy1?6 hiirimallia käytettiin 
hyväksi AMPA reseptoreiden tilan selvittämisessä tilanteessa, jossa GABAA reseptorien välittämä 
estävä viestinvälitys on muuttunut. 
 Etanoli (> 25 mM) esti AMPA reseptoreiden toimintaa lisäten reseptorin 
desensitisoitumista. Reseptorin tasannevirta oli herkempi etanolin estovaikutukselle kuin 
piikkivirta. Desensitisaation vähentäminen vähensi etanolin estovaikutusta, mikä todettiin kun 
desensitisaatiota estettiin syklotiatsidilla ja kun mitattiin ei-desensitisoituvia AMPA reseptorin 
mutatoituja muotoja. GluR-D AMPA reseptoreilla havaittiin myös, että etanoli nopeutti 
desensitisoituneeseen tilaan siirtymistä. Etanolin desensitisaatiota nopeuttava vaikutus oli suurempi, 
kun TARP proteiineja ilmennettiin AMPA reseptorien kanssa. 
 Tutkimuksissamme selvisi, että AMPA reseptorin agonistin sitomiskyvyllä on tärkeä 
merkitys reseptorin kuljettamisessa sisäsolukalvostolta solukalvolle. Stargazin-TARP palautti 
sitomiskyvyttömien AMPA reseptorimutanttien kuljetuksen normaalitasolle HEK-soluissa, muttei 
hermosoluissa. Thy1?6 hiirimallilla tehdyt kokeet osoittivat, että AMPA reseptorien toiminta oli 
vähentynyt hippokampuksen CA1 alueen hermosoluissa, mikä näkyi mEPSC amplitudin 
pienenemisenä verrattuna villityyppsiin hiiriin. Hiirikannalla oli myös alentunut 
sähköshokkiherkkyys, mikä todennäköisesti johtui vähentyneestä AMPA reseptorien toiminnasta. 
 Tulokset osoittavat, että suuret etanolin pitoisuudet estävät AMPA reseptoreita, millä 
voi olla merkitystä voimakkaassa humalatilassa. Etanolin estovaikutuksen mekanismina näyttää 
olevan reseptorin desensitisaation lisäys ja desensitisoituneeseen tilaan siirtymisen nopeutuminen. 
TARPit lisäävän etanolin estovaikutusta nopeuttaen desensitisoitumista entisestään. Ne myös 
osallistuvat AMPA reseptoreiden kuljetukseen solukalvolle. AMPA reseptorit toimintassa tapahtuu 
myös pitempi aikaista säätelyä, jolla sopeudutaan hermosolujen muuttuneeseen tasapainotilaan 
kiihdyttävän ja estävän hermoviestinvälityksen välillä.  
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Abbreviations 
 
AMPA ?-amino-3-hydyroxy-5-methyl-4-isoxazolepropionic acid 
APV (2R)-amino-5-phosphonovaleric acid; NMDA receptor antagonist 
CA cornu ammonis of the hippocampus 
CAM cell adhesion molecule 
CNS central nervous system 
DMCM methyl-6,7-dimethoxy-4-ethyl-?-carboline-3-carboxylate; GABAA inverse agonist 
EC50 effective concentration 50 %; concentration producing 50 % of maximal effect; 
also effective current producing effect in 50% of animals (IV, MES-test) 
EPSC excitatory postsynaptic current 
ER endoplasmic reticulum 
fEPSP  field excitatory postsynaptic potentials 
GABA ?-aminobutyric acid 
GABAA ?-aminobutyric acid type A receptor 
GluR-Di AMPA receptor subunit (-D indicates that D subunit out of A to D is in question; i 
= flip splice variant; o = flop splice variant) 
GRIP glutamate receptor interacting protein 
HEK293 human embryonic kidney cells 
IC50 concentration producing 50 % inhibition 
LBD ligand binding domain 
LGIC ligand gated ion channel 
LTD long term depression 
LTP long term potentiation 
MAGUK membrane associated guanylate kinase 
mEPSC miniature excitatory postsynaptic current 
mIPSC miniature inhibitiory post synaptic current 
NMDA N-methyl-D-aspartate 
PDZ PSD95-Drosophila disc large-Zonula occludens-1; protein domain, which mediate 
contacts between proteins 
PICK1 protein interacting with protein kinase C? 1 
PKC protein kinase C 
PSD-95 postsynaptic density protein of 95 kDa 
S1S2-LBD ligand binding domain of glutamate receptors 
TARP transmembrane AMPA receptor regulatory protein 
THE tonic hindlimb extension 
Thy1?6 transgenic mouse line overexpressing GABAA ?6 subunit in forebrain areas 
TM1 transmembrane spanning domain 1 (number indicates which TM-domain is in 
question) 
VTA ventral tegmental area 
WT wild type 
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1. Introduction 
 
The importance of the brain as an organ controlling our life is clear to each of us. During the last 
hundred years, the research in the field of neuroscience has revealed the basic principals of how the 
brain works. One key feature of the brain at the cellular level is that a single nerve cell, neuron, 
receives inputs from hundreds or even from thousands of other neurons. This allows the brain to 
have computational functions, which is the basis of information processing. Therefore, the brain can 
be seen as a complicated biological computer, which works so that the neurons are excited by 
excitatory inputs and inhibited by inhibitory inputs, and if the summation of these two causes an 
excitation which is above a certain threshold, the neuron fires an action potential. 
 The main excitatory neurotransmitter in the mammalian nervous system is glutamate, 
which mediates the fast synaptic signalling in most of the brain. Glutamate has several groups and 
types of receptors, among which are ?-amino-3-hydyroxy-5-methyl-4-isoxazolepropionic acid 
(AMPA)-type of glutamate receptors. AMPA receptors are important in many neural functions and 
pathological conditions. The number of them in synapses can change rapidly in many physiological 
processes and is now considered to be one of the most important mechanisms underlying synaptic 
plasticity. Plasticity of the brain, in other words, the ability to change, is an important mechanism in 
adaptation to varying environmental conditions. The most widely studied form of synaptic plasticity 
is unquestionably long term potentiation (LTP) which is thought to be one of “memory traces” of 
nervous system. There are many different initiation mechanisms for LTP, but the final result seems 
to be the trafficking of more AMPA receptors to the synapses. 
 AMPA receptors are tetramers composed of products of four genes. The expression of 
different AMPA receptor subtypes depends on developmental stage, brain regions and physiological 
situations. The expression of AMPA receptors in the cell membrane is precisely regulated in order 
to ensure that only certain type of receptors occur in synapses. In addition, transmembrane AMPA 
receptor regulatory proteins (TARPs) control trafficking, synaptic location, kinetics and 
pharmacology of AMPA receptors increasing thus the functional variation of the receptors. Since 
the neural function in many brain areas rely heavily on AMPA receptors, studies of the trafficking, 
function and pharmacology of the AMPA receptor is one of the key areas of neuroscience, to help 
understand how nervous systems work and modulate their function. 
 
Review of the Literature 
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2. Review of the Literature 
2.1 Synaptic Transmission 
 
The function of neurons in the body, whether it is transduction of sensory information in the 
peripheral nervous system or information processing in the brain, is based on electrochemical 
changes in the cell membrane, which can travel from neuron to another. It consists basically of two 
aspects (1) short pulses of voltage changes which travel via axons and dendrites and (2) chemical 
communication between the neurons based on release and reception of the chemical messenger 
molecules. The latter is called synaptic transmission, and is one of the main themes of this thesis. 
 The electrical function of neurons is based on ion movement through the cell 
membrane, which leads to the change in voltage differential across the cell membrane. Ions can not 
pass the cell membrane freely, because they carry electrical charge with them which makes them 
hydrophilic. Therefore, the neural membranes are equipped with various ion channels. When an ion 
channel opens, specific ions move rapidly across the cell membrane, shifting the cell membrane 
potential rapidly towards the reversal potential of the ion in question. The driving force of the ion 
movement is called the electrochemical gradient, which is a combination of the ion’s concentration 
and the voltage difference across the cell membrane. Under normal conditions there is, for instance, 
a strong driving force for sodium to flow inside the cell, because the concentration of Na+ is about 
ten times greater extracellularly and the cell is charged negatively intracellularly. Positively charged 
sodium ions tend to depolarize the cell. Sodium current is important in the action potential fast 
depolarizing phase. If a channel is permeable to more than one species of ions, the membrane 
potential shifts towards an average of the reversal potentials of the ions passing through the channel. 
AMPA type glutamate receptors, which are studied in this thesis work, have a non-selective cation 
channel as part of their structure, which makes them permeable to Na+ and K+. In normal conditions 
AMPA receptor channel opening leads to strong sodium influx, which depolarizes the cell. 
 Essential parts of synaptic transmission consist of presynaptic transmitter release 
machinery and postsynaptic receptors. In neurotransmission, a chemical signal molecule, a 
neurotransmitter, is released from a presynaptic neuron and bound by the receptors of the receiving, 
postsynaptic neuron. Neurotransmitter is released from the synaptic vesicles when the calcium ions 
flow in to the cell through voltage sensitive calcium channels, which open as a response to the cell 
membrane depolarization traveling via presynaptic nerve fiber, axon. Presynaptic release machinery 
is very complicated and highly organized structure involving multible different proteins (Rizo and 
Rosenmund, 2008). Molecules affecting the neurotransmitter release machinery are often very 
potent toxins, some of them having marginal use as drugs, as botulinum toxin. It is used to treat 
painful muscle spasms, and as a cosmetic treatment. Neurotransmitter is released in to the highly 
organized narrow space between the nerve cells called the synaptic cleft and it diffuses rapidly (in 
milliseconds) to the postsynaptic side where it binds to its specific neurotransmitter receptors. 
Receptors can also be located in presynaptic side of synapse or in astrocytes. There are basically 
two types of receptors, ionotropic and metabotropic receptors. Ionotropic have an ion channel as a 
Review of the Literature 
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part of their structure, which allows the ions flow through the cell membrane, causing the change in 
the membrane potential. Metabotropic receptors, on the other hand, are coupled to G-proteins, 
which mediate the effects to ion channels and intracellular signaling cascades. Ionotropic receptors 
usually participate in the signal delivery between the neurons, whereas metabotropic receptors 
modulate the actual neurotransmission, such as neurotransmitter release. Usually, each 
neurotransmitter has both ionotropic and metabotropic receptors, as is the case with the most 
abundant excitatory neurotransmitter, glutamate, and with the most abundant inhibitory 
neurotransmitter, ?-aminobuturic acid (GABA). Many medical drugs, as well recreational drugs, 
used nowadays are agonists or antagonists of neurotransmitter receptors. 
 
2.2 Excitatory and Inhibitory Neurotransmission 
 
Neurotransmitter receptors can be divided functionally into two groups, excitatory (depolarizing) 
and inhibitory receptors. The ion flow through the channel of receptor determines whether the 
neurotransmission is exciting or inhibiting. Ion flow depends on ion gradient, which is created by 
ion pumps and transporters. Transporter activity may change, which may affect the direction of ion 
flow and the type of neurotransmission. For example, early in development GABA is excitatory 
neurotransmitter, but later in more mature neurons it is inhibitory due to the activity of potassium 
chloride co-transporter KCC2 (Rivera et al., 1999). In excitation positively charged ions flow into 
the cell or negatively charged ions out from the cells, where as in inhibition positive ions flow out 
from the cell and negative ions into the cell. Excitatory ionotropic receptors are AMPA-, N-methyl-
D-aspartate (NMDA)- and kainate-type of glutamate receptors, nicotinic acetylcholine receptors, 5-
HT3-receptors and P2X receptors and inhibitory receptors are GABA-A/C and glycine receptors. 
 In excitation, ion flow depolarizes the neurons. Neuronal membrane potential in 
resting conditions is normally around –70 mV. Excitation, therefore, changes the membrane 
potential towards the lower voltage values, towards the action potential firing threshold. Excitatory 
synapses are located in dendrites from where the depolarizing pulses must travel to the soma and 
reach the action potential firing zone at the axon hillock where an action potential is initiated, which 
is the ultimate goal of excitation. In dendrites, excitatory and inhibitory inputs coming from 
different neurons can sum up or cancel each other out, which is the basis of computational 
information processes of neural networks. The majority of excitation in the brain is mediated by the 
neurotransmitter glutamate. All ionotropic glutamate receptors are cation selective ion channels, 
which are permeable to Na+ and K+ and in the case of NMDA receptors and AMPA receptors 
lacking GluR-B subunit also to Ca2+. The net movement of these ions results to depolarization. In 
addition, the Ca2+ entry has many roles in the regulation of cell function. 
 Inhibition makes the cell less likely to fire an action potential. Inhibition can be 
hyperpolarizing or shunting. In hyperpolarizing inhibition the cell membrane shifts to more 
negative potential from the resting membrane potential, like in the case of GABAA-receptor 
transmission in mature brain. In shunting inhibition, the cell membrane potential shifts to less 
negative potential, but not to the action potential firing threshold and, in addition, the cells input 
Review of the Literature 
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conductance raises, which means that the cell needs more excitation to reach the firing threshold. 
Inhibition is also divided into phasic and tonic inhibition on the basis of receptor’s synaptic or 
extrasynaptic localization, respectively. Phasic inhibition occurs in synapses and prevents the 
neurons from being excited too much during excitatory transmission and is also used to generation 
of rhythmic activities in neuronal networks. Tonic inhibition is carried out by GABAA receptors 
that are activated by spill-over of synaptically released GABA and is important, in some brain 
areas, in fine tuning the neuronal nets to respond only to a certain size and type of excitatory inputs 
(Farrant and Nusser, 2005). 
 
2.3. Balance of Neurotransmission 
 
In the brain, excitation and inhibition are often mediated by two neurotransmitter systems, 
glutamate and GABA, respectively. Neuronal information processing is thought to be controlled by 
integration and summation of both of them in synaptic function (Li et al., 2006; Schummers et al., 
2002). Therefore, a tight control between them must be maintained all the time. The relative 
contribution of molecular and cellular components to the balance of the excitation and inhibition 
may vary between the brain areas. For example, in the cerebellum, the high level of intrinsic 
inhibition is balanced by mainly excitatory afferents from various brain regions (Bower, 2002). 
Whereas various excitatory feedback loops in the hippocampus are balanced by several classes of 
interneurons to avoid hypersynchronicity and epileptiform activity (Levinson and El-Husseini, 
2005; Mann et al., 2005). It is not currently clear how neurons balance the excitation and inhibition 
at a molecular level. However, overexpression and knock down experiments have revealed 
important proteins controlling synapse formation. Recent evidences suggest that two main groups in 
the regulation of formation of excitatory synapses are postsynaptic scaffolding proteins and cell 
adhesion molecules (CAMs). Postsynaptic density proteins include members of the PSD-95 family, 
shank and homer, which have been shown to promote excitatory synapse maturation (reviewed in 
Kim and Sheng, 2004). Important cell adhesion molecules in excitatory synapse formation are 
postsynaptic neuroligins and predominantly presynaptically expressed neurexins (Dean and 
Dresbach, 2006). 
 The most abundant postsynaptic scaffold molecule that is enriched at glutamatergic 
synapses is Postsynaptic density protein of 95 kDa, (PSD-95; also known as synapse associated 
protein 90, SAP90), a member of membrane associated guanylate kinase (MAGUK) family. PSD-
95 keeps AMPA receptors at synapses by connecting to stargazin, or other members of 
transmembrane AMPA receptor regulatory proteins family (TARPs), which associate directly with 
AMPA receptors (Bats et al., 2007; Chen et al., 2000; Tomita et al., 2005). A role for PSD-95 in 
regulation of AMPA receptor trafficking and retention at the synapses has been reported in several 
studies. The first evidence that PSD-95 increases AMPA receptor recruitment and function at the 
synapses, came from cultured hippocampal neurons overexpressing PSD-95 (El-Husseini et al., 
2000). This effect of PSD-95 was specific to AMPA receptors, since NMDA receptors were not 
affected. These results were surprising, since PSD-95 was not known to link to AMPA receptors, 
Review of the Literature 
________________________________________________________________________________________________________________________ 
14 
but to directly interact with NMDA receptors. This discrepancy was solved later when the role of 
stargazin and other TARPs as auxiliary AMPA receptor subunits was established (Chen et al., 
2000). In addition, knocking down PSD-95 reduced excitation as compared to inhibition (Prange et 
al., 2004). 
 Several studies have established that postsynaptically expressed CAM family 
neuroligins (neurogilin-1, 2 and 3 are expressed in brain) are important mediators of the formation 
of excitatory synapses in synaptogenesis and that they bind to PSD-95 protein with their 
cytoplasmic tail. Neuroligins seem to influence the maturation of both excitatory and inhibitory 
synapses (Prange et al., 2004; Levinson et al., 2005), but they show type specificity, since 
neuroligins 1 and 3 are predominantly localized to excitatory synapses, while neuroligin 2 is 
localized to inhibitory synapses (Chih et al., 2006; Graf et al., 2004; Levinson et al., 2005; Prange et 
al., 2004; Song et al., 1999). The binding partners of neuroligins are mainly presynaptically 
expressed neurexins. Several studies suggest that neurexins act as the presynaptic receptor for 
neuroligins to induce presynaptic protein recruitment and formation of presynaptic terminals (Dean 
et al., 2003; Scheiffele et al., 2000). Neurexins bind with their intracellular tail to presynaptic 
proteins, like CASK, which is a PDZ domain-containing protein related to PSD-95. Through this 
interaction, neurexins are coupled to vesicle fusion machinery (Biederer and Sudhof, 2000; Butz et 
al., 1998; Hata et al., 1996). Thus, the interaction between neuroligins and neurexins may activate 
the structural formation of presynaptic protein complexes. 
 Currently, the formation of inhibitory synapses is not as well studied as the formation 
of excitatory synapses, which itself is still poorly understood. In inhibitory synapses, a key scaffold 
protein seems to be gephyrin. Gephyrin plays a significant role in the development of both GABA 
and glycine synapses. In hippocampal cultures made from gephyrin knockout mice, the clustering 
of glycine receptors to the synapses was completely abolished and the clustering of GABAA 
receptors was decreased significantly as compared to wild type cultures (Levi et al., 2004). 
Although gephyrin is not needed for the formation of GABA synapses, overexpression of kimeric 
gephyrin containing bacterial and vertebrate domains induces inhibitory synapse formation and 
inhibits the formation of excitatory synapses (Lardi-Studler et al., 2007). 
 Synapses may compete for CAMs to regulate the type and strength of synapses 
formed. For instance, when GABA activity is absent in isolated hippocampal cells a mismatch of 
presynaptic and postsynaptic components occurs (Rao et al., 2000). Gephyrin is then mistargeted to 
glutamatergic synapses, possibly due to lack of appropriate inhibitory synapse scaffolding and 
adhesion molecules. Furthermore, overexpression of gephyrin increases GABAA receptor clustering 
while reducing the number of excitatory PSD-95 clusters (Lardi-Studler et al., 2007). 
 In the healthy brain, a balance of excitation and inhibition is essential for the proper 
function, including representation of sensory information, cognitive processes such as decision 
making, sleep and motor control. An imbalance of excitation and inhibition is suggested to 
contribute to the development of several diseases including epilepsy (Brenner, 2004; Clancy and 
Kass, 2004; McCormick and Contreras, 2001; Stafstrom, 2006), schizophrenia (Konradi and 
Heckers, 2003; Lewis and Levitt, 2002; Lewis and Moghaddam, 2006), Fragile X syndrome (Huber 
et al., 2002; Weiler et al., 1997) and autism (Andres, 2002; Rubenstein and Merzenich, 2003). 
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2.3.1 Synaptic Scaling 
 
Neurons tend to balance their excitatory and inhibitory synaptic inputs to a appropriate functional 
level in a process called synaptic scaling. The strength of individual synapses is modulated to 
compensate for changes occurring in other synapses in the same neuron that would otherwise affect 
the cellular activity of whole neuron. Synaptic scaling can be seen as a homeostatic counter force 
for the synaptic plasticity. The relative strengths of individual synapses appear to be maintained, 
thus preserving the plastic changes in synaptic strength. Without this counter force, LTP would 
cause a domino-like effect which would feed forward stronger changes in the next neurons in the 
line of information flow. On the other hand, LTD would silence the subsequent neurons.  
Synaptic scaling has been shown to occur in studies, where either inhibition or 
excitation has been manipulated in various ways. For instance, a block of neuronal activity by 
tetrodotoxin (TTX) for 48 h in cultured cortical neurons caused an increase in miniature excitatory 
postsynaptic currents (mEPSC), which is probably a compensatory sensitization for decreased 
glutamatergic activity (Turrigiano et al., 1998). On the other hand, the increase of the function of 
AMPA receptors by ampakines caused a decrease in AMPA receptor subunit expression 
accompanied by the decrease of synaptic scaffolding proteins SAP97 and GRIP1 (Jourdi et al., 
2005). Chronic ethanol, which causes increased GABAA receptor function, and thus inhibits 
neuronal activity, is compensated by an increased NMDA receptor expression accompanied by 
increase in PSD-95 expression and dendritic spine size (Carpenter-Hyland and Chandler, 2006). 
Elevation of the GABAA receptor- mediated inhibition by chronically administering a 
benzodiazepine agonist, flurazepam, for one week has been shown also to elevate AMPA receptor 
function in CA1 neurons in rat hippocampus (Van Sickle and Tietz, 2002). Logically, chronic 
flurazepam treatment decreased the GABAA receptors expression, but surprisingly, NMDA receptor 
expression was also decreased (Van Sickle et al., 2002). 
 As seen in the examples mentioned above, synaptic scaling often seems to involve 
changes in the number of AMPARs (and NMDARs) at individual synapses (Perez-Otano and 
Ehlers, 2005; Turrigiano and Nelson, 2004; Watt et al., 2000) and likely presynaptic changes as 
well (Burrone et al., 2002; Burrone and Murthy, 2003). Molecular mechanisms underlying these 
changes are not well understood. Recent evidence suggest that secreted factors have a role in the 
induction of homeostatic plasticity, suggesting that key triggers for this form of plasticity may come 
from outside of the neuron. Specifically, proinflammatory cytokine tumor necrosis factor-? from 
glial cells appears to be necessary for the increase in the level of synaptic AMPARs during 
extended periods of activity blockade (Beattie et al., 2002; Stellwagen and Malenka, 2006; 
Stellwagen et al., 2005). In addition, there is evidence suggesting a role for secreted brain-derived 
neurotrophic factor (BDNF) in the opposite form of synaptic scaling, the decrease in synaptic 
strengths caused by extended periods of increased network acitivity (Rutherford et al., 1998; 
Turrigiano, 2006). 
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2.4. Phasic and Tonic Inhibition 
 
Phasic inhibition refers to synaptic inhibition and tonic inhibition to extrasynaptic inhibition. Phasic 
inhibition occurs when inhibitory synaptic receptors are activated as a response to presynaptic 
vesicle release, which is precisely timed event. Tonic inhibition, on the other hand, is mediated by 
extrasynaptic receptors, which are activated by minute concentration of ambient neurotransmitter 
leaking out of the synapses and possibly released by astrocytes. Most of the research focusing on 
tonic inhibition has concentrated on extrasynaptic GABAA receptors. Substantial amount of tonic 
conductance exists in the cerebellar granule cells (Brickley et al., 1996), granule cells of the 
hippocampal dentate gyrus (Nusser and Mody, 2002), thalamocortical relay neurons of the ventral 
basal complex, (Porcello et al., 2003), CA1 pyramidal cells (Bai et al., 2001) and in certain 
inhibitory interneurons in CA1 of the hippocampus (Semyanov et al., 2003). 
 
2.4.1 Function of Phasic Inhibition 
 
The central function of synaptic inhibition is the fine tuning of excitation and to prevent the neurons 
from being excited too much, which might lead to the development of pathological conditions, such 
as epilepsy. In addition to this, GABAergic interneurons generate and maintain rhythmic activities, 
like theta and gamma oscillations, in the hippocampus (Cobb et al., 1995; Jonas et al., 2004; 
Somogyi and Klausberger, 2005), thalamus (Huntsman et al., 1999) and olfactory bulb (Laurent, 
2002). The impact of phasic inhibition on excitation depends of the location of GABAergic 
synapses along the somatodentritic axis. Inhibition is most effective when the synapses are located 
near the soma region, whereas synapses located more distally in dendrites allow more precise fine 
tuning of specific excitatory inputs.  
 
2.4.2 Function of Tonic Inhibition 
 
The function of tonic inhibition manifests most clearly in the electrical properties of the cell 
membrane. Tonic inhibition increases the input conductance of the cell. This affects the magnitude 
and duration of the voltage responses that the cell receives, and increases the attenuation of the 
depolarizing voltage pulses with distance. When the tonic inhibition is high, the EPSCs that are 
received by the neuron cause shorter and smaller potential changes which shortens the window of 
time during which the summation of excitation coming from different synapses can happen. This 
reduces the likelihood of the action potential firing, and increases the need for synchronous 
excitation. In cerebellar granule cells tonic inhibition has been shown to shift the input current 
intensity vs. firing output curve to the right, which means that more current is needed to achieve a 
given firing rate (Brickley et al., 1996; Chadderton et al., 2004; Hamann et al., 2002). 
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2.4.3. GABAA Receptor Localization Depends on Subunit Composition 
 
The location of GABAA receptors in either synapses or extrasynaptic cell membrane depends on the 
subunit composition. To date nineteen mammalian ionotropic GABA receptor subunits have been 
cloned: ?1-6, ?1-3, ?1-3, ?, ?, ?, ? and ?1-3. Native pentameric GABAA receptors are usually 
formed such that they have two ? and two ? subunits with one ?, ?, ?, ? or ? (reviewed in Sieghart 
and Sperk, 2002). The ?1-3 form GABAC receptors. In theory, there are numerous ways of how 
GABAA receptors can assembly, but in practice only a few dozen have been shown to exist 
suggesting that there are brain region-specific expression patterns for subunits and that some sort of 
rules of assembly exist (Fritschy and Mohler, 1995; Pirker et al., 2000; Wisden et al., 1992). All 
GABAA Receptor subtypes are found in large numbers in extrasynaptic membranes, but only a 
certain subtypes are located synaptically (Nusser et al., 1995). The ?2 subunit seems to be important 
for synaptic clustering of GABAA receptors, since the deletion of ?2 leads to a marked reduction in 
the clustering of both GABAA receptors and inhibitory synapse related protein gephyrin (Essrich et 
al., 1998). A subunit that is exclusively related to the extrasynaptic localization of GABAA receptors 
is ? (Nusser et al., 1998). In addition, ?4, ?5 and ?6 containing receptors seem to be predominantly 
extrasynaptic (Brickley et al., 2001; Caraiscos et al., 2004a; Peng et al., 2002). 
 The subunit composition of GABAA receptors profoundly affects the binding and 
gating properties of the receptor. The agonist binding sensitivity is mostly affected by ? subunit, 
with ?3 conferring the highest and ?6 to the lowest EC50 values. The ? subunit seems to increase 
GABA sensitivity in some cases, such as when ?2 is changed to ? in ?4?3?2 receptor (Brown et al., 
2002), but it does not make any difference within ?1?3?2 and ?6?3?2 assemblies (Feng and 
Macdonald, 2004). In addition, extrasynaptic GABAA receptors activate after a delay during the 
GABA exposure and the single channel conductance incresses gradually indicating that some still 
unknown mechanism increases GABA sensitivity (Lindquist and Birnir, 2006). The increase in 
conductance is seen in cell-attach recordings but not in outside-out patches indicating that a soluble 
intracellular factor or process, such as kinases, phosphatases or binding proteins are required for the 
phenomenon (reviewed in Birnir and Korpi, 2007). 
 Single channel conductance of GABAA receptors depends on subunit composition. 
Receptors formed only from ? and ? subunits have a low single channel conductance of around 15 
pS, but when either ? or ? is incorporated to receptors, the conductance raises to around 25-28 pS 
(Angelotti and Macdonald, 1993; Fisher and Macdonald, 1997). Most GABAA receptors in mature 
neurons probably contain either ? or ? subunit, so there is no difference between extrasynaptic and 
synaptic receptors in single channel conductance. However, synaptic receptors seem to have higher 
mean open time and duration of burst channel opening and replacing ?2 with ? reduces both (Fisher 
and Macdonald, 1997). 
 GABAA receptor desensitization is also affected by subunit composition. Adding ?2 to 
?? receptors slows the macroscopic desensitization (Benkwitz et al., 2004; Boileau et al., 2003). 
This decreases the possibility that synaptic receptors are partially desensitized and not in fully 
prepared state to receive signals. Extrasynaptic ?-containing receptors desensitize more slowly than 
synaptic ??-containing receptors (Haas and Macdonald, 1999). For both ??? and ?????the rate of 
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desensitization is dependent on the type of ? subunit. ?1?? types desensitize more rapidly than 
?5?? (Caraiscos et al., 2004a) or ?6?? types (Tia et al., 1996). However, when ?1 is substituted by 
?6 in ??? receptors the desensitization becomes faster and more extensive (Bianchi et al., 2002). 
 
2.4.4. Modulation of Phasic and Tonic Inhibition 
 
Phasic and tonic inhibition are differently affected by endogenous modulators and drugs. The 
differences are due to differences in subunit content between synaptic and extrasynaptic cell 
membranes. For instance, benzodiazepines have an effect on GABAA receptors if the subtypes 
contain ?1, ?2, ?3 or ?5 together with two ? and ?2. Therefore, phasic inhibition is generally 
affected by benzodiazepines, whereas tonic inhibition is affected only in the brain areas where 
substantial number of extrasynaptic receptors are composed of benzodiazepine-sensitive ? and ?2 
subunits (Bai et al., 2001; Caraiscos et al., 2004a; Hamann et al., 2002; Nusser and Mody, 2002; 
Semyanov et al., 2003; Yeung et al., 2003). An agonist that activates more extrasynaptic than 
synaptic receptors is 4,5,6,7-tetrahydroisothiazolo-[5,4-c]pyridin-3-ol (gaboxadol, THIP), which is 
a partial agonist of ?4?3?2 receptors, but full or “super” agonist of ?4?3? (Belelli et al., 2005; 
Chandra et al., 2006; Cope et al., 2005). 
 Tonic inhibition seems to be highly sensitive to various clinically relevant agents, for 
example, endogenous neuroactive steroids, intravenous and inhalation anaesthetics and ethanol. The 
function of GABAA receptors containing ? subunit are selectively enhanced by neurosteroids 
(Belelli et al., 2002; Brown et al., 2002). In brain slice experiments low concentrations of 3?,21-
dihydroxy-5?-pregnan-20-one (THDOC) increases the tonic conductance without affecting the 
phasic currents in granule cells of dentate gyrus and cerebellum (Stell et al., 2003). In cultured 
hippocampal neurons the tonic conductance has been shown to be enhanced by anaesthetics 
isoflurane (Caraiscos et al., 2004b) and propofol (Bai et al., 2001). Ethanol has been long suggested 
to enhance the function of GABAA receptors, but there has been great controversy about the 
subject: The results have not been reproducible between laboratories (Korpi et al., 2007). A few 
studies show that ethanol might affect extrasynaptic receptors. The mainly extrasynaptically located 
?4/?6?3?-containing GABAA receptors have been reported to be sensitive to low concentrations of 
ethanol when expressed in oocytes (Wallner et al., 2003; Sundstrom-Poromaa et al., 2002). There 
are also some studies showing that native GABAA receptors are sensitive to ethanol. Low 
concentrations of ethanol have been shown to enhance the tonic inhibition in hippocampal slices 
(Wei et al., 2004) and GABA-evoked currents in isolated hippocampal neurons (Sundstrom-
Poromaa et al., 2002). 
 
2.4.5. Thy1?6 Mice as a Model of Increased Tonic Inhibition 
 
Tonic conductance is very demanding to measure electrophysiologically, because its amplitude is 
generally very small. Tonic inhibition appears in patch clamp recordings as a higher cell membrane 
conductance, which shows itself as higher holding current and current trace noise (Kaneda et al., 
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1995). Tonic conductance can be blocked by saturating concentration of GABAA antagonist and the 
difference in current levels before and after antagonist application is the amplitude of the tonic 
conductance. In some brain areas, like CA1 of the hippocampus, the measurement of tonic 
conductance requires the usage of GABA uptake blockers or addition of low concentration (100 nM 
to 300nM) of GABA in the recording solution (Wallner et al., 2006). 
 Thy1?6 is a mouse model of increased tonic conductance. The mice overexpress 
GABAA receptor ?6 subunit under the thy1.2 promoter in various forebrain brain areas including 
CA1 of the hippocampus. This leads to an increase of extrasynaptic GABAA receptors. Pyramidal 
neurons of CA1 area of the hippocampus of these mice have a fivefold increase in tonic 
conductance as compared to wild types and, surprisingly, about 30 % decreased synaptic GABAA 
activity measured as mIPSC frequency and amplitude (Wisden et al., 2002). This animal model has 
been used to study the effect of gaboxadol on anxiolysis and sedation (Saarelainen et al., 2008). 
Gaboxadol has a strong anxiolytic effect in Thy1?? mice for the light : dark exploration and 
elevated plus-maze tests at doses which did not show any effect with wild types. In addition, 
gaboxadol also had a stronger effect on loss of the righting reflex in Thy1?? mice than wild type 
controls. The results suggest that tonic inhibition can play a role in anxiolysis and in sedation, 
offering a possible target for medical treatment of anxiety and sleep disorder.  
Thy1?6 mice have altered convulsion sensitivity. They are more prone to convulsions, 
which are induced by GABAA receptor inverse agonist DMCM (methyl-6,7-dimethoxy-4-ethyl-?-
carboline-3-carboxylate) and GABAA receptor antagonist picrotoxinin (Sinkkonen et al., 2004). On 
the other hand, GABA uptake inhibitor tiagapine delayed the onset of DMCM and picrotoxinin 
induced convulsions in Thy1?6 mice but not in wild types (Sinkkonen et al., 2004). The results 
suggest that synaptic inhibition is more efficient in protecting the mice from convulsions induced by 
GABAA receptor blocking drugs. However, are these mice also more sensitive to electroshock 
convulsions, which probably involve AMPA receptor-mediated function? AMPA receptors have 
been shown to have a role in electroshock convulsions, since these type of convulsions are inhibited 
by administration of AMPA receptor inhibitors (Micale et al., 2002; Yamashita et al., 2004). 
Another interesting question about Thy1?6 mice is: How is AMPA receptor-mediated synaptic 
function as compared to wild type mice? Are synaptic scaling processes scaling down the AMPA 
receptor function to match the level of decreased synaptic GABAA function? One aim of our 
research was to clarify the status of AMPA receptor driven excitation in the hippocampus of 
Thy1?6 mice. 
 
Summary. Phasic inhibition is mediated by synaptic GABAA receptors and it participates in fast 
synaptic neurotransmission counterbalancing the fast synaptic excitation. Phasic inhibition also has 
roles of its own in the creation of oscillatory activity in some brain areas. Tonic inhibition is 
mediated by extrasynaptic receptors and is activated by low ambient concentration of GABA 
spilling over from synapses. Tonic inhibition increases the input conductance of neurons, thus 
increasing the currents that are needed to generate action potentials. Subunit composition primarily 
defines mostly which receptors are located in synapses, with certain subtypes being exclusively 
extrasynaptic. The different subunit composition between the extrasynaptic and synaptic receptors 
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also confers different drug sensitivities. The functional properties of synaptic and extrasynaptic 
receptors correlate well with their physiological roles. Synaptic receptors have lower GABA 
sensitivity, as compared to extrasynaptic receptors, and GABA has a high efficacy on them. On the 
other hand, extrasynaptic receptors have a high binding affinity for GABA, but GABA has a low 
efficacy on them. In addition, extrasynaptic receptors are modulated by endogenous signal 
molecules, like neurosteroids, which allows the modulation of large neural networks on a relatively 
fast time scale, in other words without the synthesis of new proteins. Synaptic scaling is an 
important process that balances the alterations in synaptic strength, keeping the overall activity of 
the neuron at the functionally relevant level. 
 
2.5 Ligand-gated Ion Channels 
 
In this thesis work, the function of one type of ligand-gated ion channels, AMPA receptors, are 
studied in various pharmacological and physiological situations. Ligand-gated ion channels 
(LGICs) a.k.a. ionotropic receptors, mediate fast postsynaptic potential changes. LGICs are found 
both in peripheral and central nervous systems, where they mediate various functions. For instance, 
they function to get the skeletal muscles to contract and allow signals to travel from neuron to 
neuron. They are found on the cell membrane, usually in close proximity to the release site of 
neurotransmitter, and are opened when agonist binds to them permitting the movement of ions 
through the cell membrane. LGICs are divided into three ligand-gated ion channel superfamilies. 
The Cys-loop LGIC-superfamily is comprised of nicotinic acetylcholine, GABAA, GABAC, glycine 
and 5-HT3 receptors. They are composed of five protein subunits and possess a characteristic loop 
formed by a disulfide bond between two cysteine residues. Ionotropic glutamate receptors form the 
second LGIC-superfamily, which includes AMPA, kainate and NMDA receptors that are composed 
of four subunits (Rosenmund et al., 1998). Each subunit has three membrane-spanning ?-helixes 
and one re-entrant membrane loop. The third family, ATP-gated channels (P2X receptors), are 
composed of three subunits, each subunit having two plasma membrane spanning domains, a large 
extracellular loop and intracellular carboxyl and amino termini. 
 
2.5.1 Desensitization of LGICs 
 
One key feature of LGICs is desensitization. Desensitization is defined as the state of the receptor 
where the ion channel is closed in the presence of agonist molecule in the binding pocket of the 
receptor. Desensitization of LGICs is seen in electrophysiological recordings as a peak current 
decay during relatively long agonist applications (Fig. 1A). In this type of recording the current first 
has a clear peak component followed by a steady state current. The peak component results from a 
large number of receptors opening simultaneously due to rapid application of high concentration of 
agonist. Shortly after the current peaks, receptors start to desensitize leading to decay phase of the 
peak current. Single or polynomial fit of peak current decay can be used to determine a time 
constant of desensitization, ?-value, which is a measure of the rate of desensitization. During steady 
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state current the individual receptors are either open or desensitized. The proportion of open 
channels can be estimated by comparing the steady state current amplitude to peak current 
amplitude, which produces the SS/peak-ratio, a measurement of extent of desensitization (Fig. 1B). 
SS/peak ration and ?-value of desensitization varies greatly between different receptors and 
differing subunit compositions. It should be mentioned that the measurement of exact peak current 
by electrophysiological recording techniques is very demanding and requires conditions where the 
agonist application occurs extremely fast. If the agonist application is slower, the peak current 
results from a receptor pool containing some desensitized receptors. Molecular mechanisms of 
AMPA receptor desensitization have been clarified with X-ray crystallography and are discussed in 
chapter 2.8.6. Mechanisms of AMPA Receptor Activation and Desensitization and illustrated in 
figure 5. 
 
 
Figure 1. desensitization of LGIC; GluR-Di receptors. A) example trace of patch clamp 
recording of GluR-Di AMPA receptors expressed in HEK293 cells. In the figure the 
different current components, peak and steady state current are shown. Horizontal bar 
indicates application of 10 mM glutamate. B) shows the peak component of the current 
trace enlarged in order to illustrate the determination of the time constant of 
desensitization (?-value) from peak current decay with single exponential fit (dashed line). 
The SS/peak ratio, a measure of the extent of desensitization, is the relationship of steady 
state current amplitude to peak current amplitude, in this case 170 pA / 3696 pA = 0.046.  
 
2.6 Glutamate as a Neurotransmitter 
 
L-Glutamate is the major excitatory neurotransmitter in the mammalian central nervous system 
(CNS) acting through both ligand-gated ion channels and G-protein coupled receptors. Major 
glutamatergic pathways in the brain are the cortico-cortical pathways, the pathways between the 
thalamus and the cortex, and the extrapyramidal pathway (the projections between the cortex and 
striatum). Important glutamatergic projections exist also between the cortex, substantia nigra, 
subthalamic nucleus and pallidum (Carlsson, 1995). 
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 L-Glutamate can be termed a work-horse of the vertebrate central nervous system, 
since probably every central neuron receives glutamatergic excitation. Glutamate receptors 
participate in fast synaptic neurotransmission, but they also have a major role in the plastic changes 
in the efficacy of synaptic transmission thought to underlying learning and memory, and the 
formation of neuronal networks during development. For instance, AMPA receptors are 
constitutively recycled in and out of cell membrane, and their number can be rapidly changed to 
produce alterations in synaptic strength like, long term potentiation (LTP) and long term depression 
(LTD) (Esteban, 2003). Metabotropic glutamate receptors modulate the function of glutamatergic 
and also other synapses (Ferraguti and Shigemoto, 2006; Swanson et al., 2005). 
 Neuronal glutamate is synthesised by astrocytes and neurons in a metabolic cycle 
called glutamate/GABA- glutamine cycle (Fig. 2) (Bak et al., 2006). Neurons are unable to 
synthesize glutamate de novo from glucose and need help from astrocytes to get their glutamate in 
the form of glutamine. In the synthesis cycle astrocytes take up the glutamate that is released from 
the glutamatergic neurons during neurotransmission and transform it to glutamine by astrosyte-
specific glutamine synthetase enzyme. Glutamine is then released into the extracellular space from 
where it is taken up by glutamatergic neurons and transformed back to glutamate by phosphate 
activated glutaminase. Interestingly, astrocytes and glutamine have also a similar role in synthesis 
pathway of GABA. Astrocytes take up GABA from extracellular space and cycle that through 
tricarboxylic acid cycle to produce glutamate and then glutamine. Glutamine is released back to 
extracellular space and taken up by GABAergic neurons, where it is converted first to glutamate 
and then to GABA by glutamate decarboxylase. Astrocytes are the cells predominantly responsible 
for extrasynaptic glutamate clearance. The most important glutamate uptake molecules are 
astroglial excitatory amino acid transporter 1 and 2 (EAAT1 and 2), which are considered to be 
largely responsible for glutamate up-take throughout the brain (Danbolt, 2001). The other uptake 
transporters are EAAT3-5, which have regional significance in glutamate clearance. Glutamatergic 
neurons are dependent on astrocytes to get their glutamate, since they do not express enough 
glutamate transporters of their own to supply the demand of glutamate. 
 
2.7 Glutamate Receptors 
 
2.7.1 AMPA Receptors 
 
AMPA receptors have four subunits, which are transcribed from genes which are located in humans 
in 4, 5, 11 and X chromosomes (Fig. 3). Alternative splicing and RNA editing increase the variation 
of subunits. A functional receptor is composed of four subunits and is usually heteromeric, although 
GluR-A homomers are thought to exist during the synaptic plasticity (Derkach et al., 2007; 
Wenthold et al., 1996). Molecular domains of receptor consist of a large extracellular N-terminus, 
an extracellular loop, three transmembrane spanning helixes (TM1, 3 and 4), a membrane re-entrant 
loop (TM2), and intracellular C-terminus. Glutamate binding domain is formed as a combination of 
part of the extracellular N-terminus, also called as ligand binding domain 1 (S1) and an extracellular 
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loop between TM3 and TM4, called as ligand binding domain 2 (S2). AMPA receptor subunits 
have several unique features, which alter their function and physiological properties, which are 
discussed below in the chapter 2.8 Characteristics of AMPA receptors. Figure 4 shows a schematic 
presentation of AMPA receptor structure. 
 
 
 
Figure 2. Glutamate-glutamine cycle. Astrocytes take up the glutamate (Glu) released 
from neurons during the neurotransmission. The uptake is done by excitatory amino acid 
transporters (EAATs), which also clear glutamate from extracellular space. In the 
astrocytes glutamate is converted to glutamine (Gln) by enzyme glutamine synthetase 
(GS). Glutamine is then transported to extracellular space and then to neuron by the 
activity of sodium-coupled neutral amino acid (System N/A) transporters (SNAT) 
(Mackenzie and Erickson, 2004). Glutamine is converted back to glutamate by 
mitochondrial phosphate-activated glutaminase (PAG). Glutamate is then packed in the 
synaptic vesicles by vesicular glutamate transporters, (VGLUTs) after which glutamate is 
ready for release. TCA = tricarboxylic acid; GluRs = postsynaptic glutamate receptors. 
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2.7.2 NMDA Receptors 
 
NMDA is a full agonist of ionotropic glutamate receptor subgroup, NMDA receptors. They are 
abundantly distributed through the CNS in excitatory synapses along with AMPA receptors. The 
NMDA receptors assemble as a combination of two mandatory NR1 subunits and two NR2A-
NR2D subunits (Fig. 3). In order for the NMDA receptor channel to open both glutamate and co-
agonist glycine (or D-serine) are required to bind to NR2 subunits and NR1 subunits, respectively. 
NMDA receptors also possess binding sites for polyamines and protons (McBain and Mayer, 1994). 
NMDA receptors have also NR3A and B subunits, which lower the receptor currents, reduce Mg2+ 
block and reduce the inflow of Ca2+(Cavara and Hollmann, 2008). 
The function of NMDA receptors differs from AMPA receptors in two ways which 
have important physiological consequences. First, during normal neurotransmission, they are silent, 
because Mg2+ blocks the channel. Mg2+-block is removed during strong synaptic activation 
(depolarization), making NMDA receptors a postsynaptic activity sensor able to detect 
neurotransmission which is above of certain strength. Secondly, NMDA receptors let Ca2+ flow into 
the cell, which activates downstream intracellular Ca2+ sensing machinery, which may lead to 
alteration of the strength of synapse, in other words to LTP or LTD. The role of NMDA receptors is 
well characterized in the prototypic form of synaptic plasticity, NMDA receptor-dependent LTP. It 
is initiated after strong Ca2+ entry and the subsequent activation of intracellular kinases, most 
importantly calmodulin-dependent kinase II (CaMKII). NMDA receptor-dependent LTD, on the 
other hand, follows after moderate elevation of intracellular Ca2+ leading to preferential activation 
of protein phosphatases, which leads to dephosphorylation of proteins in postsynaptic density (PSD) 
leading to removal of AMPA receptors from the synapses (Dudek and Bear, 1992). 
 
2.7.3 Kainate Receptors 
 
Kainic acid, or kainate, is a partial agonist of AMPA receptors, but a full agonist of the closely 
related ionotropic glutamate receptor subgroup, called kainate receptors. Kainate receptors are 
abundantly expressed throughout the CNS, located in both pre- and postsynaptic compartments. The 
physiological role of kainate receptors is not as well understood as that of AMPA and NMDA 
receptors. Presynaptic kainate receptors can rapidly regulate the glutamate release and therefore 
affect the short-term dynamics of synaptic transmission. Kainate receptors have been found to 
increase glutamate release in mossy fiber synapses in the hippocampus and function as a source for 
calcium entry initiating LTP formation (Bortolotto et al., 2003). During early development of CA3-
CA1 synapses in the hippocampus, kainate receptors lower the glutamate release probability and 
therefore set the synapses to respond to high frequency burst activity typical to developing synaptic 
connection (Lauri et al., 2006). 
Native kainate receptors are composed either homomeric or heteromeric KA1, 2, 
GluR-5, -6 and -7 subunits. GluR5-7 have 75-80 % amino acid identity with each other and 40 % 
with GluR-A-D AMPA receptors. KA1 and 2 share 70 % amino acid identity with each other and 
40 % with GluR5-7 kainate receptor subunit and GluR-A-D AMPA receptor subunits. Similarly to 
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GluR-B (see below), GluR5 and GluR6, but not GluR7, have a Q/R-RNA editing site in the M2 
segment. In contrast to GluR-B, the Q/R site editing is incomplete during development, and 
significant amounts of both edited and unedited versions coexist in adult brain. There are two 
additional editing sites in M1 of GluR6 subunit, [I(isoleucine)/V(valine) and Y(tyrosine)/ 
C(cysteine)]. Alternative splicing of GluR5 further adds to receptor diversity (reviewed in Seeburg, 
1993). 
 
 
Figure 3. Dendrogram of the members of the ionotropic glutamate receptor family. Amino 
acid identity between the subunits can be calculated subtracting 100% minus the sum of 
the length of the horizontal solid lines between the two subunits. For example, the % 
identity in the amino-acid sequence between GluR-A and GluR-B is the distance of GluR-A 
and GluR-B to each nearest node (15% and 14%), respectively on the dendrogram, and 
the distance between these two nodes is 2%, resulting in a total of 15%+ 14%+ 2%=31%. 
Therefore, the identity in the amino-acid sequence between them is (100% - 31%)= 69%. 
Dashed line indicates low (ca. 20 %) amino-acid identity between subunit groups which 
are not used for estimating the distance. NC-IUPHAR stands for nomenclature committee 
of The International Union of Basic and Clinical Pharmacology, which have formulated and 
suggested new names for glutamate receptors (Collingridge, et al., 2009). Figure modified 
from Ozawa (1998). 
2.7.4. Metabotropic Glutamate Receptors 
 
There are eight metabotropic glutamate receptors (mGluR’s), which are divided into three 
subgroups based on their amino acid sequence homology and pharmacological characteristics called 
group I (contains mGluR1 and 5), II (mGluR2 and 3) and III (mGluR4, 6, 7 and 8) (Conn and Pin, 
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1997). Group I mGluRs are coupled to phospholipase C, which hydrolyze phosphoinositide 
producing inositol triphosphatases, which leads to increase in intracellular calcium (Yuzaki and 
Mikoshiba, 1992). They are also reported to inhibit voltage dependent calcium channels in 
hippocampus by straight interaction between the activated G-protein and the calcium channel 
(Lester and Jahr, 1990; Swartz and Bean, 1992). Group II of mGluRs are coupled to the inhibition 
of synthesis of cyclic AMP by activation of a G-protein that inhibits adenylyl cyclase enzyme (Baba 
et al., 1993; Prezeau et al., 1994), and they also inhibit calcium channels (Choi and Lovinger, 1996) 
and activate a G-protein coupled inwardly rectifying K+-channel (GIRK) (Knoflach and Kemp, 
1998). Group III of mGluRs also couple negatively to cAMP production and they also inhibit the 
neurotransmission by inhibition of presynaptic voltage-dependent calcium channels (Takahashi et 
al., 1996). 
 The main function of mGluRs is the control and adjustment of glutamate transmission. 
They are located in pre- and postsynaptic side of both excitatory and inhibitory synapses, 
sometimes far away from release sites, and also in astrocytes (illustrated in Swanson et al., 2005). 
They also participate in plastic changes of synaptic strength, such as mGlu dependent LTP in the 
hippocampus (Bellone and Luscher, 2005) and LTD in the cerebellum (Lante et al., 2006) to name a 
couple of examples. Activation of mGluRs by synaptically released glutamate may sometimes 
require high-frequency or repetitive stimulation, because receptors are located extrasynaptically on 
axons and dendrites. Receptors might be activated by the glutamate spilling over from release sites 
from far away making possible the cross talk between different synapsies, even between the 
different pathways. The location of mGluRs differs between the subunits.  
 Metabotropic glutamate receptors are not currently target molecules of any drugs, but 
they are studies as a potential targets to treat of several diseases. Blockage of group I mGluRs and 
activation of group II mGluRs are studied as a treatment for Parkinson’s disease, as they control 
glutamatergic and cholinergic neurotransmission in striatum (Bonsi et al., 2007). mGluR receptor 
acting drugs are also studied as a treatment for stress and anxiety disorder. Agonists for group II 
mGlu receptors and antagonists for group I (in particular mGluR5) receptors have shown activity in 
animal and/or human conditions of fear, anxiety or stress (Swanson et al., 2005). In addition, a 
growing body of evidence suggests that metabotropic glutamate receptors also play important roles 
in the behavioural responses to drugs of abuse and participate in producing synaptic plasticity at 
glutamate synapses. Many studies show that group I receptors have a role in cocaine-related 
behaviours (Backstrom and Hyytia, 2006; Chiamulera et al., 2001; Dudek and Bear, 1992; Herzig 
and Schmidt, 2004; Hu et al., 1999). mGluR5 specific antagonists, MPEP and MTEP, attenuate 
cocaine-related behaviors such as cue-induced relapse to cocaine seeking (Backstrom and Hyytia, 
2006; Chiamulera et al., 2001; Herzig and Schmidt, 2004;). These antagonists also disrupt 
reinforcing properties of alcohol (Lominac et al., 2006). 
 
Summary. Glutamate is the major excitatory neurotransmitter in the brain. It has three classes of 
ionotropic receptors, AMPA, NMDA and kainate receptors and eight metabotropic receptors, 
mGluR1-8. AMPA receptors mediate the fast excitatory neurotransmission between the neurons. 
The number of synaptic AMPA receptors can be altered rapidly making it possible to adjust the 
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synaptic strength. NMDA receptors are normally closed by Mg2+-block, but can open during a 
strong AMPA receptor-mediated depolarization. NMDA receptors are permeable to calcium, which 
leads to the plastic changes of synaptic strength, like LTP and LTD. Kainate receptors control the 
activity of glutamatergic cells in some brain areas. Metabotropic receptors modulate the glutamate 
release and participate also in the induction of LTP and LTD. 
 
2.8 Characteristics of the AMPA Receptors 
2.8.1. Splice Variants of AMPA Receptors 
 
All AMPA receptor subunits have two splice variants called “flip and flop”, the alternative splicing 
site being in the extracellular loop near the ligand binding domain S2 (Fig. 4). During early 
development, the flip forms of AMPA receptor subunits are more prominent, whereas in 
adolescence, the “flip” subunits are replaced by “flop”-containing subunits (Monyer et al., 1991). 
AMPA receptors containing “flip” subunits generally desensitize with slower kinetics than those 
with “flop” subunits (Mosbacher et al., 1994). 
 The second alternative splicing site is the intracellular C-terminus of the GluR-B and 
GluR-D subunits, which can be expressed either as “long” or as “short” isoforms. The C-terminal 
splicing pattern is developmentally controlled (Köhler et al., 1994). The amino acid sequence of C-
terminal domain of GluR-Blong and GluR-Dlong are related to that of GluR-A. Early in the 
development of the central nervous system, GluR-Blong and GluR-Dlong might have a similar 
function in AMPA receptor trafficking as GluR-A in adults (Kolleker et al., 2003). In adults, the 
prevalent GluR-B transcript codes for the short C-terminal tail (Kolleker et al., 2003). Long and 
short forms of C-tails bind to different synaptic scaffold proteins and protein kinases. C-tail splice 
variants have therefore important role in regulation of the appearance and function AMPA receptors 
in synapses (Barry and Ziff, 2002; Braithwaite et al., 2000; Sheng and Lee, 2001; Song and 
Huganir, 2002). 
 
2.8.2 Nuclear RNA Editing 
 
Nuclear RNA editing increases the diversity of AMPA receptors in the TM2 region in GluR-B and 
ligand binding domain 2 in GluR-B, GluR-C and GluR-D (Fig. 4). The RNA editing of GluR-B M2 
leading to a change of glutamine (Q) to arginine (R) at the protein level, has very important 
functional consequences since the receptor containing this subunit becomes calcium impermeable. 
The mechanism of editing is by a nuclear adenosine deaminase, ADAR2 that causes a conversion in 
the RNA from a codon for glutamine to that for an arginine (Sommer et al., 1991). In the adult 
brain, most excitatory neurons express AMPA receptors that contain R/Q-edited GluR-B, making 
them impermeable to calcium (Seeburg et al., 1998). Calcium permeable AMPA receptors are still 
found in glia cells and GABAergic interneurons (Geiger et al., 1995; Muller et al., 1992). The 
editing of the other AMPA receptor RNA-editing site at the third extracellular loop, just upstream 
of the flip/flop cassette, speeds up the recovery from desensitization (Fig. 4) (Lomeli et al., 1994). 
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Figure 4 Topology of the AMPA receptor. (A) Scheme of AMPA receptor subunit in the 
plasma membrane in association with a transmembrane AMPA receptor protein (TARP). 
N-terminal domain (NTD), extracellular ligand binding domains (S1 and S2), 
transmembrane domains (M1-4), the flip/flop alternative splicing site and the RNA editing 
sites (Q/R and R/G) are also shown. Two headed arrow indicates the interacting domains 
between AMPA receptor and TARP. (B) Three-dimensional representation of the 
tetrameric AMPA receptor depicting the arrangement of one subunit within the complex. 
M2 region, which lines the channel and S1/S2 ligand binding domain are highlighted. 
Figure modified from Ashby et al. (2007). 
 
2.8.3. AMPA Receptor Distribution 
 
AMPA receptors are distributed ubiquitously throughout the CNS, although regional differences in 
the distribution are evident. Brain areas rich in AMPA receptors include CA1 and CA3 areas of 
hippocampus, dentate gyrus and superficial layer of cerebral cortex. Lower levels are found in the 
diencephalon, midbrain, brainstem and cerebellum. The expression of AMPA receptor subunits 
differ between the brain areas and developmental stages. GluR-A and GluR-B subunits are 
ubiquitously expressed in the brain and therefore are probably present in most AMPA receptors in 
the adult mammalian CNS (Keinänen et al., 1990). GluR-C mRNA is found in hippocampal and 
cortical cell layers and in the Purkinje cell layer of the cerebellum (Keinänen et al., 1990). GluR-D 
subunit is expressed mainly in the early development (Zhu et al., 2000) and is a predominant 
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AMPA subunit in a few brain areas such as the granule cells of the olfactory bulb and in the 
molecular layer of the cerebellar cortex (Keinänen et al., 1990). 
 
2.8.4. Proteins Interacting with AMPA Receptors 
 
AMPA receptors are assembled in ER (Tichelaar et al., 2004). After the assembly, the receptors 
undergo tightly regulated quality checking for agonist binding and gating. After this the receptors 
are escorted to dendritic synaptic and extrasynaptic cell membranes. The studies during past 
decades have revealed several groups of proteins that participate in the formation, trafficking and 
synaptic targeting and maintenance of AMPA receptors. 
 TARPs (Letts et al., 1998) have been found to control the trafficking of AMPA 
receptors from the endoplastic reticulum and connect them in synapses. Nowadays, TARPs may be 
considered as auxillary AMPA receptors subunits (Fukata et al., 2005) that assist receptor folding, 
affect their kinetics (Bedoukian et al., 2006; Priel et al., 2005; Tomita et al., 2005; Turetsky et al., 
2005) and rectification (Soto et al., 2007). TARP ?2, also known as stargazin, is a prototypical 
TARP. It was found by a spontaneous mutation in the stargazer mouse line that completely lacked 
surface expression of AMPA receptors in cerebellar granule cells (Chen et al., 2000). Stargazin 
affects the AMPA receptor function by decreasing the rate and extent of desensitization and 
increasing the efficacy of partial agonist kainate (Turetsky et al., 2005). According to a recent 
study, TARPs can be divided into two groups, Type I and Type II TARPs (Kato et al., 2008). Type 
I TARPS, stargazin, ?3, ?4, and ?8, have a similar effect on AMPA receptors, albeit the extent of the 
effects differs between the TARP subunits (Kott et al., 2007). Type II TARPs, ?5 and ?7, do not 
seem to participate in the trafficking of AMPA receptors, but regulate AMPA receptor function in 
subunit specific manner (Kato et al., 2008; Kato et al., 2007). Important domains of TARP structure 
for their regulation of AMPA receptors are the first extracellular loop which makes contact with the 
glutamate-binding module in AMPA receptors (Tomita et al., 2007) and thereby modulates channel 
gating and pharmacology (Fig 4), and the C-terminal tail which associates with postsynaptic 
density-95 and related membrane-associated proteins, which cluster AMPA receptors at synapses 
(Schnell et al., 2002). TARPs contain a PDZ-interacting motif in the C terminus, which can bind the 
PDZ domain of membrane-associated proteins like membrane associated guanylate kinase 
(MAGUK) scaffolding proteins (Chen et al., 2000). 
 Very recent study has revealed that members of family of transmembrane proteins, 
chornichon homologs CNIH-2 and CHIN-3, associate with AMPA receptors, and like TARPs, also 
affect the trafficking and kinetics of AMPA receptors (Schwenk et al., 2009). Surprisingly, the 
study showed stronger association of chornichons with AMPA receptors than TARPs, as majority 
(ca. 70 %) of AMPA receptors were found in a complex with CNIH-2 and CHIN-3, only a minor 
portion associating with most widespread TARPs, ?2 and ?3.  
PSD-95 is a PDZ domain-containing scaffolding protein, which belongs to the 
MAGUK-protein family. It is almost exclusively located in the postsynaptic density of neurons. 
PSD-95 controls synaptic AMPA receptor content and thereby synaptic strength. Acute 
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overexpression of PSD-95 increases AMPA receptor-mediated EPSCs, but not NMDA receptor 
EPSCs in hippocampal neurons, while acute knockdown of PSD-95 via RNA interference (RNAi) 
decreases AMPAR EPSCs, but not NMDA EPSCs (Ehrlich and Malinow, 2004; Ehrlich et al., 
2007). PSD-95 also appears to have a role in synaptic plasticity, since hippocampal slices prepared 
from mutant mice lacking PSD-95 expressed greatly enhanced NMDA receptor-dependent LTP, but 
they did not express NMDA receptor-dependent LTD (Migaud et al., 1998). Overexpression of 
PSD-95, on the other hand, occluded LTP (Ehrlich and Malinow, 2004; Stein et al., 2003) and 
decreased the threshold for LTD induction (Beique and Andrade, 2003; Stein et al., 2003). 
SAP97 (synapse-associated protein 97) is a member of the MAGUK family of 
proteins that has been implicated in AMPA receptor transport to and from the synapses. It binds 
directly only to long C-terminus containing GluR-A (Cai et al., 2002). SAP97 appears to 
predominantly associate with GluR-A subunits early in the secretory pathway and has been 
suggested to function during receptor maturation, not anchoring, of GluR-A at synapses (Sans et al., 
2001). However, other studies localize SAP97 to excitatory synapses, and overexpression of SAP97 
can enhance synaptic AMPA receptor function and promote dendritic spine growth (Rumbaugh et 
al., 2003). GluR-A and SAP97 together are reported to promote dendrite branching in an activity-
dependent manner, although this does not seem to require physical association between them (Zhou 
et al., 2008). 
N-ethylmaleimide-sensitive fusion protein (NSF) is a membrane fusion protein that 
has ATPase activity. Together with PICK1 (protein interacting with protein kinase C? 1), it has a 
role in the delivery of GluR-B subunit containing AMPA receptors to the cell membrane during 
synaptic activation. Blocking either PICK1 or NSF with peptides added to pipette solution prevents 
the delivery of GluR-B containing AMPA receptors to the synapses (Gardner et al., 2005; Liu and 
Cull-Candy, 2005). PICK1 is a PDZ-domain containing protein that interacts with glutamate 
receptors, monoamine plasma membrane transporters and non-voltage gated sodium channels, and 
is a target of protein kinase C (Xu and Xia, 2006). 
Glutamate receptor interacting protein (GRIP) is important in clustering of AMPA 
receptors at the synapses. GRIP binds to GluR-B subunit C-terminus with its PDZ domain. The 
phosphorylation of Ser880 in the intracellular C-terminal domain of GluR-B by PKC decreases the 
association of GluR-B and GRIP. It has been speculated that this phosphorylation has a specific role 
in the formation of LTD at parallel fiber-Purkinje cell synapses in the cerebellum (reviewed in 
Hirai, 2001). 
 
2.8.5. AMPA Receptor Synthesis and Trafficking to the Cell Membrane 
 
Glutamate receptor subunits are synthesized by endoplasmic reticulum (ER)-associated rhibosomes. 
Each of the glutamate receptor (except GluR7) contains an N-terminal signal sequence that targets 
insertion in the ER membrane. Tetrameric AMPA receptor assembly takes place in ER, where they 
are assembled as dimer of dimers (Ayalon and Stern-Bach, 2001; Tichelaar et al., 2004). 
Dimerization starts from N-terminal LIVBP-like domain (Fig. 4). It is suggested that the N-
Review of the Literature 
________________________________________________________________________________________________________________________ 
31 
terminus assures that the association happens between the subunits of only a given ionotropic 
glutamate receptor family, thereby preventing the association of AMPA receptor subunits to kainate 
receptor subunits (Ayalon and Stern-Bach, 2001; Kohda et al., 2003). This is probably based on 
differences in chemical properties of dimer interfaces in N-terminus between subunits families, in 
AMPA receptors being more hydrophopic and in kainate receptors more polar (Ayalon et al., 2005). 
However, large N-terminus is not mandatory for AMPA receptor folding and trafficking to the cell 
membrane, since GluR-D receptors lacking N-terminus are expressed as efficiently as wild type 
GluR-D receptors in HEK cells (Pasternack et al., 2002). Assembly of the dimers in the formation 
of tetramers probably happen step by step towards the C-terminus after the ligand binding domains 
and transmembrane domains have folded (reviewed in Greger and Esteban, 2007). 
ER has quality control machinery that allows forward trafficking of certain glutamate 
receptors, while retaining others in ER. The purpose of this system is to assure that only appropriate 
and rightly formed glutamate receptors are trafficked further to the cell membrane. The exact 
molecular mechanisms of how the quality control works are not known to date, but studies with 
various point mutated glutamate receptor subunits have revealed what properties are checked. The 
quality control seems to especially target checking functional elements of receptors, such as ligand 
binding domain residues (Fleck et al., 2003; Grunwald and Kaplan, 2003; Mah et al., 2005; Valluru 
et al., 2005), dimer-interface residues (Fleck et al., 2003; Horning and Mayer, 2004) and channel 
pore residues at or near the Q/R editing site (Greger et al., 2002; Grunwald and Kaplan, 2003). 
 Desensitization seems to play a role in forward trafficking of AMPA receptos. For 
example, L483Y point-mutated GluR-B is retained largely in ER (Greger et al., 2006). L483Y 
mutation affects ligand binding domain such that the receptor does not desensitize properly. In 
addition, kainate receptor mutants with an engineered disulfide bridge across the ligand binding 
domain interface, which also does not desensitize, have drastically reduced surface expression (Priel 
et al., 2006). On the other hand, N754D GluR-B mutant that has accelerated desensitization, is 
trafficked to the neuronal cell membrane more efficiently than wild type GluR-B (Greger et al., 
2006). 
 The exit of AMPA receptors from ER is facilitated by the interaction with TARPs. 
This is evident for at least the flop form of GluR-D that is expressed poorly in the cell membrane of 
HEK cells, but the surface expression raises to the level of GluR-D flip, when stargazin is 
coexpressed with it (Coleman et al., 2006). 
 AMPA receptors are trafficked at synapses in a subunit-dependent manner. The 
general rule, at least in the hippocampus, is that GluR-B/GluR-C receptors cycle constitutively in 
and out of synapses and GluR-A containing receptors are inserted to synapses in activity-dependent 
manner during LTP (Hayashi et al., 2000; Passafaro et al., 2001; Shi et al., 2001). The hypothesis 
for this difference in subunit specific membrane trafficking is that long C-tail splice variants 
containing receptors are added to synapses in activity dependent-manner and sort tail containing 
receptors are constitutively cycled. Receptors are delivered to synapses possibly via two different 
routes, directly to postsynaptic density or by lateral diffusion. Direct insertion to the synapses 
occurs via exocytosis (Gerges et al., 2006). Lateral diffusion involves trapping of the wandering 
AMPA receptors by PDZ-dependent interaction between TAPRs and PSD95 scaffold proteins. 
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Lateral diffusion has been observed almost exclusively in primary neuronal cultures, whereas 
evidence for intracellular trafficking has been seen in both brain slices and dissociated neurons 
(Greger and Esteban, 2007). It may be so that the lateral diffusion occurs in developing neurons and 
intracellular insertion in mature neurons. However, it should be mentioned that aforementioned 
difference might be artificial due to technical reasons, since in cortical cultures the lateral diffusion 
is easier to observe than in brain slice preparations. 
 
2.8.6 Mechanisms of AMPA Receptor Activation and Desensitization 
 
AMPA receptors undergo rapid and extensive desensitization. In AMPA receptors the ?-value of 
desensitization of homomeric receptors is fastest with GluR-D flop-splice variant (GluR-Do) being 
0.9 ms and slowest in GluR-C flip (Glur-Di), 4.8 ms, when 1 mM glutamate is applied rapidly 
(Mosbacher et al., 1994). ?-value of desensitization of AMPA receptors in native neurons range 
from 1 to 16 ms (Barbour et al., 1994; Colquhoun et al., 1992; Geiger et al., 1995; Hestrin, 1992; 
Tang et al., 1989; Trussell and Fischbach, 1989). The SS/peak-ratio of AMPA receptors is usually 
around 0.1 or lower, meaning that 90 % or over of the receptors are desensitized in each time point 
during steady state current. 
 The X-ray crystal structure analysis of isolated ligand binding domain (LBD) of 
AMPA receptors, with and without the agonist, has revealed how ligand binding converts to 
channel pore opening. LBD of AMPA receptor crystalizes as dimers, so that the backsides of two 
LBDs form a dimer interface (Fig. 5). Closure of the clam shell shaped LBD, after agonist binding, 
leads to opening of the channel, with a full agonist causing more closure than partial agonists 
(Armstrong and Gouaux, 2000; Hogner et al., 2002). The LBD of an AMPA receptor connects to 
transmembrane domain M3 (Fig. 4 and 5) with a linker segment which is thought to stretch when 
the LBD closes. It has been suggested that stretching of the linker segment cause reorientation of 
TM-domains, which converts to channel opening (Sobolevsky et al., 2005). Agonist binding also 
decreases the stability of LBD interface of dimers, which results in desensitization by allowing the 
repositioning of transmembrane domains in more relaxed confirmation, in which the ion channel 
can close (Sun et al., 2002). 
 
2.8.7. Genetically Modified AMPA Receptor Mouse Lines 
 
In order to study the role of specific AMPA receptor subunits in synaptic plasticity and learning and 
memory behaviours, several genetically engineered AMPA receptor mouse lines have been 
generated. In GluR-A knock out mice, hippocampal LTP is absent in field excitatory postsynaptic 
potential (fEPSP) recordings (Zamanillo et al., 1999) and they have an impaired regulation of 
distance-dependent scaling of excitatory postsynaptic currents, EPSCs, along the dendrite 
(Andrasfalvy et al., 2003). In addition, they do not have LTP-like potentiation in ventral tegmental 
area (VTA) after an injection of cocaine (Dong et al., 2004). In behavioural studies, GluR-A knock  
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Figure 5. Activation and desensitization AMPA receptors. A very simplistic scheme of 
three states of AMPA receptor is depicted in the figure. Receptor can be open, closed or 
desensitized. The transition between these states does not require any energy, but is a 
stochastic process. The receptor constantly undergoes some fluctuations between the 
states even in the absence of agonist. However, agonist binding increases markedly the 
probability of receptor to be open and when agonist binding lasts longer, several 
milliseconds, probability is highest for the desensitized state. When agonist leaves the 
surrounding environment, the receptor closes in a process called deactivation. Movements 
of AMPA receptor domains involved in activation and desensitization of the receptor are 
marked with arrows and numbers and are: 1.) closure of LBD; 2.) stretching of the linker 
sequence which cause the movement of the transmembrane domains and channel 
opening (3.); 4.) decrease of the stability of LDB dimer interface which relaxes the 
conformation leading to (5.) the repositioning of transmembrane domains and channel 
closure. Modified from Madden 2002. 
 
outs do not respond to cues that were conditioned to reward (Mead and Stephens, 2003b) and they 
have altered conditioned place preference behaviour towards cocaine (Dong et al., 2004). 
 AMPA receptor subunit GluR-B renders AMPA receptors Ca2+ impermeable. GluR-B 
knock outs exhibit increased mortality, and those surviving show reduced exploration and impaired 
motor coordination. GluR-B subunit knock outs have enhanced LTP in hippocampus, probably due 
to 9-fold increased Ca2+ permeability (Jia et al., 1996). GluR-B knock out mice have altered 
stimulus reward learning (Mead and Stephens, 2003a). 
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 GluR-C knock out mice are viable and have normal locomotor activity. They also 
have normal CNS anatomy and synaptic structures (Meng et al., 2003). However, GluR-C knock 
outs do have enhanced LTP in the CA1 region of hippocampus. When GluR-C knock outs are bred 
with GluR-B knock outs to produce double knock outs, AMPA fEPSPs in the hippocampus are 
significantly smaller, being only 10-20 % of the level of wild types. However, synaptic plasticity 
processes, LTD, LTP, depotentiation and depression are present in these mice (Meng et al., 2003). 
These data suggest that GluR-A alone is sufficient to produce various forms of synaptic plasticity. 
This is probably because the primary mechanism for LTP (especially in the hippocampus) is likely 
the insertion of GluR-A containing AMPA receptors to the synapses, and LTD occurs as a result of 
removal of all types of AMPA receptors equally from the synapses. 
 
Summary. AMPA receptors have many special features which have significance for their function. 
The expression of AMPA receptor subunits varies between the brain regions and is developmentally 
regulated. In brain AMPA receptors seem to be interacting with various proteins, which participate 
in synthesis and assembly of tetrameric receptors in ER, trafficking of receptors to the cell 
membrane and synapses and retention of them in synapses. The TARPs have especially emerged as 
an important family of AMPA receptor interacting proteins, because they affect trafficking, synaptic 
localization, gating and pharmacology of AMPA receptors. AMPA receptors are constitutively 
recycled in and out of synapses, which is mainly done by GluR-B/C AMPA receptors, and added to 
the synapses when required primarily in the form of GluR-A containing receptors. 
 
2.9 Pharmacology of Ionotropic Glutamate Receptors 
 
Glutamate receptors play the central role in signaling of neurons and neural plasticity in virtually all 
brain areas. In theory, this makes them tempting drug targets, but AMPA receptor subtypes do not 
differ enough from each other to make it possible to affect only a certain aspect of brain function. In 
addition, to date only a few molecules affecting glutamate receptors show subunit selectivity. 
 Drugs affecting the ionotropic glutamate receptors are only used in a small set of 
clinical indictions. Ketamine is an anesthetic, which blocks the channel of NMDA receptor. It is not 
used generally in anesthesia, but has been used in special cases, like veterinary medicine and animal 
anesthesia in research. Topiramate is a drug used in epilepsy and migraine. It has many molecular 
targets, e.g. it inhibits kainate and AMPA receptors. In Alzheimer’s disease, memantine, a NMDA 
channel blocker is used to slow down the progress of the disease. Memantine is thought to decrease 
pathologically elevated glutamatergic function. Glutamate receptor potentiators, so called 
ampakines, are currently being researched as cognition enhancing drugs to treat diseases involving 
mental disability like Alzheimer's disease, Parkinson's disease, schizophrenia, depression and 
ADHD (Lynch, 2006). 
 In research, many NMDA, AMPA and kainate receptor agonist and antagonists have 
been used. Traditionally, ionotropic glutamate receptors have been divided into two crude groups: 
NMDA and non-NMDA receptors, mainly because of the drug selectivity. AMPA and kainate 
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receptor pharmacology is very similar, and it has not been possible to pharmacologically isolate 
only one of them until recently, when the commercially available selective compounds arrived. 
Most commonly used synthetic agonists to activate AMPA and NMDA receptors are AMPA and 
NMDA, respectively. Blockage of AMPA receptors can be accomplished by 6,7-
dinitroquinoxaline-2,3-dione (DNQX), 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) or 2,3-
Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline -7-sulfonamide (NBQX) and NMDA 
receptors are usually blocked by (2R)-amino-5-phosphonovaleric acid (APV) or channel blocker 
MK-801 (dizocilpine). In figure 6 examples of glutamate receptor currents are shown to 
demonstrate the isolation of NMDA and AMPA currents using NMDA antagonist APV. 
 
 
Figure 6. Representative traces of excitatory postsynaptic currents of glutamate receptors 
measured from VTA (ventral tegmantal area) dopamine neuron at the holding potential of 
+40 mV and in the presence of picrotoxn. GluR EPSC = baseline EPSC containing both 
AMPA and NMDA receptor conductances; AMPAR EPSC = AMPA receptor EPSC, 
recorded in the presence of APV; NMDAR EPSC, generated by subtracting GluR EPSC – 
AMPAR EPSC. The dotted line represents zero current level. The stimulus artefact is 
omitted for clarity. Note the typical short duration of AMPA receptor current and longer 
duration of NMDA receptor current. 
 
2.10. Ethanol 
 
Ethanol (ethyl alcohol) has a wide variety of effects on many type of proteins expressed in central 
nervous system. Even though several target molecules of ethanol have been identified during past 
decades, it is not still clear which of them are important in ethanol intoxication and the development 
of alcohol dependency. One clear difficulty in studying the effects of ethanol is that ethanol does 
not bind with high affinity to biomolecules. Therefore, binding assays are not possible with ethanol, 
which makes it difficult to prove that ethanol has a direct action on biomolecules. In the next few 
chapters the current knowledge of ethanol’s central nervous system effects are reviewed starting 
from historical theories about lipid membrane action ending with effects on proteins. 
 
2.10.1. Theories of How Ethanol Causes Its Effects 
 
The first theory of how ethanol and general anesthetics produce their effect arose at the end of 
nineteenth century, when H. H. Meyer published a study suggesting that these compounds produce 
their action by interaction with lipid membranes. A couple of years later a similar theory was 
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published independently by Overton. Therefore, the theory is known as Meyer-Overton’s lipid 
theory of anesthesia (reviewed in Lovinger, 1997). Meyer and Overton had discovered a most 
striking correlation between the physical properties, mainly lipid solubility, of general anaesthetic 
molecules and their potency. Meyer compared the potency of many agents required to induce 
anaesthesia in tadpoles, with their olive oil/water partition coefficient. He found a nearly linear 
relationship between potency and the partition coefficient for many types of anesthetic molecules 
such as alcohols, aldehydes, ketones and esters. From the correlation between lipid solubility and 
anesthetic potency, both Meyer and Overton proposed that anesthesia occurs when the anesthetic 
reaches a critical concentration in some lipid phase within the body. However, the logic is not 
flawless; general anesthetics could equally well be binding to hydrophobic target sites on proteins in 
the brain. In fact, the necessity for general anesthetics to cross the blood-brain barrier to have their 
effect is the main reason that more polar agents are less potent. However, the theory prevailed for 
80 years. 
 In 1984 Franks and Lieb published a study showing that ethanol inhibited the function 
of firefly luciferase enzyme. The experiments were done with soluble protein, proving that alcohols 
and general anesthetics can produce action without the lipids. Soon, others followed providing 
evidence that ethanol affects the function of many neurotransmitter receptors. First, it was shown 
that ethanol enhances the function of GABAA receptors (Aguayo, 1990; Allan and Harris, 1986; 
Nakahiro et al., 1991; Suzdak et al., 1986; Wafford and Whiting, 1992). Next, the function of 
NMDA receptors was found to be inhibited by ethanol (Hoffman et al., 1989; Lovinger et al., 
1989), followed by the studies showing that ethanol potentiates serotonin 5-HT3 receptors 
(Lovinger and White, 1991; Machu and Harris, 1994), potentiates strychnine-sensitive glycine 
receptors (Aguayo and Pancetti, 1994; Celentano et al., 1988; Mascia et al., 1996), either potentiates 
(Aistrup et al., 1999; Bradley et al., 1984; Wu et al., 1994) or inhibits (Aistrup et al., 1999) the 
nicotinic acetylcholine receptors in a subunit dependent manner. Ethanol has been also shown to 
affect other proteins than just ionotropic receptors. Among these are adenosine (Krauss et al., 1993), 
norepinephrine (Lin et al., 1997), dopamine (Wang et al., 1997), and serotonin (Alexi and Azmitia, 
1991) transporters and calcium channels (Camacho-Nasi and Treistman, 1986; Mullikin-Kilpatrick 
and Treistman, 1995). In addition, several studies show that a variety of protein kinases play a role 
in ethanol actions (Freund and Palmer, 1997; Harris et al., 1995; Hodge et al., 1999; Miyakawa et 
al., 1997; Rabbani et al., 1999; Yoshimura and Tabakoff, 1999). 
 Data showing that ethanol changes the function of proteins are not enough as such to 
prove that ethanol has a direct effect on them. Ethanol could as well affect still unknown target 
molecules, which then downstream affect the protein in question. More direct evidence that ethanol 
binds directly to the proteins came from studies where glycine and GABAA receptors were point-
mutated to produce receptors that were insensitive or less sensitive to ethanol, respectively (Mihic 
et al., 1997). The same group also demonstrated that the size of ethanol binding pocket, or more 
precisely the hydrophilic cavity which ethanol can be accommodated, in glycine and GABAC ?1 
receptors can be changed by point mutation resulting in a change in cut-off point of n-alcohols 
(Wick et al., 1998). 
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 Action of ethanol on its many acute targets in brain produces its unique action profile, 
which causes the feeling of drunkenness when alcohol drinks are consumed. In addition, ethanol 
also possesses features that are shared between many types of drugs of abuse. Ethanol along with 
other drugs of abuse and benzodiazepines seems to cause LTP-like potentiation of AMPA receptor 
function selectively in dopamine cells of ventral tegmental area (VTA) in midbrain after a single 
injection in mice (Heikkinen et al., 2008; Saal et al., 2003; Ungless et al., 2001). These data mean 
that drugs of abuse activate one of the brains reward pathways starting from VTA and targeting 
nucleus accumbens where dopamine is released. The physiological role of VTA dopamine neurons 
in learning was demonstrated in monkey studies measuring the firing rate of dopamine cells using 
intracranial recording electrode (Hollerman and Schultz, 1998). On the basis of those experiments 
we can conclude, that the firing rate of dopamine cells raises when an animal observes in its 
environment a novel object that it links to something that satisfies its bodily needs or when an 
animal comes across an environmental cue that has been previously linked to something that 
satisfies its bodily needs. It has been thought that the increase in dopamine released in nucleus 
accumbens enhances the memory of valuable things found in the environment by adding a feeling 
of satisfaction or pleasure in the memory. This has a survival value to the animal. Since ethanol and 
drugs of abuse activate the reward pathway, the use causes pleasurable feelings and makes the users 
more prone to use that particular substance again in the future. 
 To find an answer to the question, what makes a drug have abuse potential is one of 
the main goals of addiction studies. The activation of the brain reward pathway answers sufficiently 
to that question. Molecules that are used as drugs of abuse seem to target this pathway directly at 
the molecular level (reviewed in Kauer, 2004), instead of first functioning somewhere else in brain, 
and then downstream activating the reward pathway. In this view, the acute changes outside of the 
reward related areas, that are sensed during the use of drugs, are secondary and do not contribute to 
the need for usage, which leads to the development of dependency. To find out if this hypothesis is 
true, we should have a drug of abuse that only targets reward pathways. Are there such drugs? The 
answer obviously is no, but stimulants, especially cocaine, comes close. Cocaine is a dopamine 
transporter blocker, and also has effects on the uptake of other monoamines. Cocaine produces a 
rush that is described as a state of well being with high self esteem and alertness (Koob and 
Le Moan, 2005). Interestingly, ethanol also has stimulant-like effects sometimes, especially after a 
few drinks, even though it is a depressor of neural function and clearly sedative at high 
concentrations. Maybe the stimulant-like, arousing, effect of alcohol is because ethanol also 
activates the VTA-nucleus accumbens reward pathway. 
 
2.10.2. Effects of Ethanol on NMDA Receptors 
 
It is not currently clear which molecular targets of ethanol are important in ethanols acute effects, 
but GABAA and NMDA receptors are generally considered to be the most probable candidates. 
GABAA receptors are reported to be potentiated by low and moderate concentrations of ethanol 
(Soldo et al., 1994; Wallner et al., 2003; Weiner et al., 1997), albeit there is a controversy in the 
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topic (Korpi et al., 2007). Ethanol inhibits the function of all classes of glutamate receptors, and 
NMDA receptors have been most intensively studied. 
 Ethanol has been shown to inhibit the function of NMDA-type glutamate receptors in 
intact synapses and in heterologous expression systems (Blevins et al., 1997; Lovinger et al., 1990; 
Wirkner et al., 2000). Ethanol inhibits NMDA receptor currents in clinically relevant concentrations 
(5-50 mM), IC50 being around 30 mM (Weight et al., 1993). Inhibition seems to be dependent on 
subunit composition of NMDA receptors. A study of NR1/NR2A, NR1/NR2B, and NR1/NR2C 
subunit combinations expressed in Xenopus oocytes shows that NR1/NR2C channels were slightly 
less sensitive to ethanol inhibition than the other channels in Ca2+-deficient, Ba2+-containing 
medium (Kuner et al., 1993). The other Xenopus oocytes expression study showed that NR1 
combined with NR2A was the most sensitive, NR1/NR2B a little bit less sensitive and NR1/2C 
combination the least sensitive to ethanol’s inhibition (Mirshahi and Woodward, 1995). In the same 
study, the ethanol inhibition of NR1/2A receptors was reduced by substitution of the wild type NR1 
with a calcium-impermeable NR1 mutant suggesting that intracellular processes activated by 
calcium may influence the inhibitory potency of ethanol. In native neurons, the most sensitive 
receptors seem to be NR2B containing, ifenprodil sensitive, NMDA receptors (Fink and Gothert, 
1996; Lovinger, 1995), suggesting that subunit composition does not explain as a whole the 
differences observed in ethanol inhibition of NMDA receptors. 
 The C-tail of NR1 subunit contains the C0 domain that binds to calmodulin and 
actinin binding protein ?-actinin-2 (Krupp et al., 1999). C0 domain has been shown to play a part in 
ethanol inhibition of NMDA receptors (Anders et al., 2000). Calmodulin binding to the C0 domain 
mediates the calcium-dependent reduction of NMDA receptor function (Krupp et al., 1999; 
Legendre et al., 1993). Calmodulin and ?-actinin-2 seem to compete for NMDA receptor 
interaction, calcium concentration being the factor that determines the outcome of the competition. 
It is suggested that in the presence of elevated calcium NMDA receptor inactivation occurs after C0 
dissociates from ?-actinin-2 by two distinct but converging calcium-dependent processes; 
competitive displacement of ?-actinin-2 by calmodulin and the reduction in the affinity of ?-
actinin-2 for C0 after calcium binds to it. Ethanol inhibition of NR1/NR2 combinations lacking C0 
domain is reduced in HEK293 cell expression studies (Anders et al., 2000). These results show that 
ethanol inhibition is stronger if calcium- and calmodulin-dependent inactivation NMDA receptors 
are let to function properly suggesting that ethanol promotes calmodulin-dependent inactivation of 
NMDA receptors.  
 Certain amino acid substitutions in NMDA receptors have also been shown to affect 
ethanol sensitivity. In NR1 subunit, a point mutation F639A in TM3 region reduces ethanol 
inhibition and F639W slightly increases it (Ronald et al., 2001). In addition, point mutations 
M813A and L819A in TM4 of NR1 subunit enhance the ethanol inhibition (Smothers and 
Woodward, 2006). When the ethanol sensitivity reducing F639A (TM3) point mutation is combined 
with either L819A (TM4) or G822W (TM4) point mutations, the ethanol inhibition returns to the 
level of wild type receptor (Smothers and Woodward, 2006). The data can be interpreted such that 
TM3 and TM4 domains form a binding cavity for ethanol and increasing the volume of this cavity 
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by substituting the phenylalanine with smaller amino acids at position 639 may be compensated by 
the expression of the larger residues such as tryptophan at the TM4 domain. 
 
2.10.3 Effects of Ethanol on AMPA Receptors 
 
 AMPA receptors are not generally thought to be as sensitive to ethanol as NMDA 
receptors. They are not much inhibited in intact synapses, when the currents are activated by 
synaptically released glutamate evoked by electrical stimulation of afferent axons (Carta et al., 
2003; Hendricson et al., 2003; Lovinger et al., 1989; Lovinger et al., 1990; Weiner et al., 1999). The 
only brain areas where ethanol has been found to inhibit synaptic AMPA receptor currents to date 
are central amygdala (Zhu et al., 2007) and CA3 area of Hippocampus of neonatal rats (Mameli et 
al., 2005). Interestingly, in latter AMPA receptor currents are sensitive to ethanol and NMDA 
receptor currents are not, where as the opposite is true in 21-26 days old rats (Mameli et al., 2005). 
However, AMPA receptors seem to be equally sensitive to ethanol as NMDA receptors in 
experiments where currents are activated by relatively long agonist applications both in native 
neurons and in expression systems (Lovinger 1993; Wirkner et al., 2000). AMPA receptors 
desensitize strongly (about 90 %) when the drugs are applied to the cells using relatively long drug 
application times, common in cell culture and heterologous expression studies. However, when 
neurons are stimulated electrically in intact brain slices the receptors are generally non-desensitized 
or only slightly desensitized. Can the difference in the extent of desensitization explain the observed 
differences in ethanol inhibition of AMPA receptors? One aim of our research was to investigate 
this possibility. 
 As mentioned above, ethanol does not generally efficiently inhibit synaptic AMPA 
receptor currents. In hippocampus, 100 mM ethanol has been reported to inhibit the amplitude of 
AMPA receptor mediated population EPSP only by 9 %, where as in the same study 50 mM of 
ethanol inhibited NMDA receptor population EPSPs by 43 % (Lovinger et al., 1990). In amygdala, 
where synaptic AMPA receptors are significantly inhibited by ethanol, 44 mM ethanol inhibits 
AMPA receptor mEPSC by 30 % (Zhu et al., 2007) and in neonatal CA3 of hippocampus 50 mM 
ethanol inhibited EPSCs by 30 % (Mameli et al., 2005). In studies making use of drug application 
systems ethanol IC50-values of AMPA receptor currents varied depending on subunit composition 
and cell types. In HEK293 cell experiments IC50-value of ethanol varied from 119 to 165 mM 
depending on subunits expressed (Lovinger, 1993). In oocyte experiments IC50-value of kainate 
activated AMPA receptor currents depended also on expressed subunits and varied from 170 to 238 
mM (Akinshola et al., 2003). Heteromeric AMPA receptors have a higher IC50 than homomeric; 
homomeric A and D receptors had IC50 values of 119 and 133 mM, respectively; coexpressed A/D 
heteromers IC50-value was raised to 165 mM (Lovinger, 1993). In cultured cortical neurons the 
IC50-value seemed to depend on the agonist used as kainate evoked AMPA currents gave IC50-value 
of ethanol of around 400 mM (Lovinger, 1993), whereas when AMPA was used as agonist IC50-
value was 162 mM (Wirkner et al., 2000). 
Review of the Literature 
________________________________________________________________________________________________________________________ 
40 
Ethanol inhibits AMPA receptors in non-competitive manner and the ethanol 
inhibition is reproducible and reversible as currents return back to control level after ethanol 
application (Wirkner et al., 2000). Straight-chain alcohols show cut-off phenomenon in ethanol 
inhibition of AMPA receptors, which means that the potency to inhibit AMPA receptors grows with 
chain length (or hydrophobicity) of alcohol molecules, but only to certain point, which is hexanol. 
This suggests that ethanol has a binding site in AMPA receptor, which is reachable via hydrophobic 
milieu, such as lipid membrane (Akinshola, 2001). 
 
2.10.4 Effects of Ethanol on Kainate Receptors 
 
 Kainate receptors are inhibited by ethanol in heterologous systems and neuronal 
cultures in concentrations greater than 25 mM (Costa et al., 2000; Dildy-Mayfield and Harris, 1995; 
Valenzuela and Cardoso, 1999; Valenzuela et al., 1998). Kainate receptors in synaptic transmission 
seem to be sensitive to ethanol in pyramidal neurons in CA3 of hippocampus even more than 
NMDA receptors and AMPA receptors (Weiner et al., 1999). In CA1 region of hippocampus 
kainate receptors are located in presynaptic terminals of interneurons, where their activation 
increases GABA release (Cossart et al., 2001). These kainate receptors seem to be sensitive to low, 
5-10 mM, concentration of ethanol, which has been reported to decrease the interneuron firing, thus 
decreasing the GABA mediated inhibitory input to the CA1 pyramidal neurons (Carta et al., 2003).  
 
Summary. Glutamate receptors are targets of several medical and recreational drugs. However, 
they are not generally considered as good targets for drugs, because they have too wide a role in 
brain functions, thus usually inducing too many adverse effects. Ethanol inhibits the function of all 
classes of glutamate receptors in some experimental conditions. However, in most experiments only 
NMDA receptors have been shown to be inhibited by clinically relevant concentration of ethanol. 
The ethanol inhibition of AMPA receptors seems to depend on experimental conditions, and it is 
not known to what degree ethanol would affect synaptic AMPA receptor currents. Ethanol effects 
on kainate receptors have significance in some brain areas, like in the hippocampus, where it 
decreases interneuron firing through the inhibition of kainate receptors. 
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3. Aims of the Study 
 
The aim of this thesis work was to study the ethanol inhibition of AMPA receptors and how the cell 
membrane expression of AMPA receptors is regulated. These studies were done with patch clamp 
electrophysiology and immunostaining and immunoblotting methods. The specific aims were the 
following: 
 
 
1. to clarify the mechanisms of ethanol inhibition of native AMPA receptors 
 
2. to study the role of TARPs in ethanol inhibition of AMPA receptors 
 
3. to study what properties of AMPA receptors affect the early trafficking of them to the cell 
membrane from ER 
 
4. to study the state of AMPA receptor-mediated excitation in Thy1?6 mice which have 
altered GABAA receptor-mediated inhibition 
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4. Materials and Methods 
4.1. Experimental Animals and Expression Systems 
 
Male and female C57BL/J6 wild type mice were used for hippocampal neuron isolation in Study I. 
Wild type C57BL/J6 and Thy1-?6 mice were used in study IV. For Study IV, all experimental 
procedures were approved by the Institutional Animal Use and Care Committee of the University of 
Turku and by the Western Finland Provincial Government.  
 Human embryonic kidney cell line (HEK293) was used in Study I, II and III and in 
addition COS7 cells were used in study III. 
 
4.2. Cell Culture (I, II, III) 
 
HEK293 cells and COS7 cells were cultured in DMEM supplemented with 10% foetal calf serum 
and 2 mM L-glutamine and penicillin-streptomycin solution. Cells were kept in culture incubator at 
37 ?C in 5 % CO2. Cells were split every second or third day, when the culture was confluent. 
 
4.2.1. Plasmids (I, II, III) 
 
GluR-A flip plasmid used in HEK293 cell transfection was kindly donated by Dr. Kathryn Partin 
(I). Plasmids of GluR-D subtype of AMPA receptors and various point mutated GluR-D receptors, 
as well as TARP-plasmids were kindly donated by Dr. Kari Keinänen. TARP plasmids, human 
stargazin (?2) and ?4 were originally from John L. Black III (Mayo Medical School, Rochester, 
MN). 
 
4.2.2. Antibodies (III) 
 
Primary antibodies used in immunofluorescence staining were monoclonal M1anti-Flag (Sigma; 5 
g/ml), and Fab7 and Fab22 (both at 10 g/ml). Secondary antibody used was Cy3- conjugated anti-
mouse (7 g/ml) from Jackson ImmunoResearch Laboratories. For immunoblotting, anti-GluR-
BDLONG (Coleman et al., 2006) or anti-stargazin (1:5000) made in-house were used. Commercial 
antibodies used were rabbit anti-myc (AbCam; 0.1 g/ml) and rabbit anti-NMDAR1 (Chemicon; 0.2 
g/ml); secondary antibody used was anti-rabbit conjugated to horseradish peroxidase (Amersham 
Biosciences; 1:5000). 
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4.2.3. Immunofluorescence Analysis (III) 
 
Transfected COS-7 cells were fixed and immunostained 40 h after transfection. Images were 
obtained and analyzed with an Olympus Provis AX70 epifluorescence microscope coupled to a 
Photometrics SenSys air-cooled CCD camera and Image ProPlus software. 
 
4.2.4 Cell Surface Biotinylation, Protein Secretion, and Immunoblot Quantification (III) 
 
Transfected HEK293 cells were biotinylated with EZ-Link Sulfo-NHS-SS-Biotin (Pierce). Triton 
X-100 extracts were bound to streptavidin-conjugated Sepharose (Amersham Biosciences), and 
precipitated proteins were harvested and analyzed. For analysis of GluR-D S1S2 construct 
secretion, growth media were collected from transfected HEK293 cells 40 h after transfection, and 1 
mM PMSF was added. Cell debris was pelleted by centrifugation (1500 g, 5 min, 4°C). Samples of 
media and total cell extracts prepared in Triton X-100 were analyzed by SDS-PAGE and 
immunoblotting. Immunoblots were scanned via Adobe Photoshop and analyzed using Image 
ProPlus software. 
 
4.2.5. Endoglycosidase H Treatment (III) 
 
Triton X-100 extracts from transfected cells were incubated with Endoglycosidase H (New England 
Biolabs) according to manufacturer’s instructions. 
 
4.2.6. HEK293 Cell Transfection (I, II, III) 
 
Before the transfection the cells were replated at a density of 2 × 105 cells per millilitre into 35 mm 
culture dish. Cells were transfected using the calcium phosphate method (2 µg AMPA receptor and 
TARP plasmids and 0.7 µg EGFP DNA per 35 mm dish) (Coleman et al., 2003). The media was 
changed 18 hours after the transfection, and the cells were used for patch clamp experiments the 
following day. In each transfection in study II, both the GluR-D plasmid alone and GluR-D plus 
TARP plasmid were transfected in order to minimize the variation between the transfection 
conditions. All the cells were cotransfected with pEGFP-C1 for visualization of EGFP fluorescence. 
 
4.3. Slice Preparation (I, IV) 
 
C57Bl/J6 mice (10–20 days old) were decapitated and the whole brains were moved to ice-cold 
high-sucrose cutting solution. Coronal brain slices (400 µm in thickness) were cut using a manual 
vibroslice (Camden Instruments Ltd., Leicester, UK). Slices were kept at room temperature in 
artificial cerebrospinal fluid. 
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4.3.1. Isolation of Hippocampal Cells (I) 
 
Hippocampal cells were isolated from 400 µM coronal brain slices. The brain slices were first 
incubated in pronase-enzyme (0.4–0.6 mg/ml; Calbiochem, San Diego, CA) in artificial 
cerebrospinal fluid at 37 °C for 20 to 30 min depending on age of mouse. Slices from younger 
animals require shorter incubation times. After incubation the slices were transferred to trituration 
buffer and the hippocampus was isolated from rest of the slice using a scalpel and sharp forceps. 
Neurons were dissociated by gentle mechanical trituration with differing sizes of fire-polished 
Pasteur pipettes. Cells were then allowed to settle to the bottom of a 35-mm-diameter culture dish, 
which was then transferred to the stage of an inverted microscope. 
 
4.3.2. fEPSP Recordings from Hippocampal Stratum Radiatum 
 
In a still unpublished study, we investigated the sensitivity to ethanol of AMPA receptor-mediated 
field excitatory postsynaptic potentials (fEPSP). fEPSP recordings of stratum radiatum of 
hippocampus were done using glass electrode which was filler with 1 mM NaCl, which was placed 
on stratum radiatum area of hippocampus. The extracellular solution was ACSF (for content, 
chapter 4.4.1.) The fEPSPs were evoked by stimulating the afferent Schaffer collateral axons 
placing the bipolar stimulation electrode few hundred µm apart from recording electrode on stratum 
radiatum. NMDA receptor blocker APV was used in recording solution during the experiment. 
Ethanol was diluted in the bath solution. fEPSP’s were recorded using axoclamp 2A amplifier and 
pClamp 7 software (Molecular Devices, Sunnyvale CA, USA). 
 
4.4. Patch Clamp Technique (I, II, III, IV) 
 
Patch clamp is an electrophysiological recording technique, which allows the recording of ion 
current from a single cell. In patch clamp a small sized recording electrode is placed on the 
membrane of the cell and the cell membrane is sucked towards the electrode. This results in a seal 
between the electrode and the cell membrane, which has a high resistance of gigaohms. This makes 
it possible to record the cell membrane currents even at the single channel level. The patch clamp 
experiments can be done in current or voltage clamp mode. There are four different configurations 
in patch clamp which are; whole cell, cell-attached, outside-out and inside-out (Hamill et al., 1981). 
All the patch clamp studies in this thesis work have been done using whole cell voltage clamp, 
except one data set in the study I, which was done using outside-out membrane patches with voltage 
clamp mode. 
 
4.4.1. Patch Clamp Solutions (I, II, III, IV) 
 
Patch clamp recordings are done using solutions that resemble in their ion content physiological 
extracellular and intracellular milieus. Slice recordings (IV) were done in artificial cerebrospinal 
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fluid (ACSF), which contains (in mM) 126 NaCl, 1.6 KCl, 1.2 MgCl2, 2.5 CaCl2, 18 NaHCO3, 1.2 
NaH2PO4, and 11 D-glucose. The solution is bubbled with 95% O2/5% CO2 when it is used. Pipette 
solution in brain slice experiments contained (in mM) 120 CsMeSO3, 5 NaCl, 10 TEA-Cl, 10 
HEPES, 1.1 EGTA, 4 Mg-ATP, and 0.3 Na-GTP, pH adjusted to 7.2 with CsOH. Studies with 
acutely isolated neurons (I) and HEK293-cell (I, II, III) experiments were done in external solution 
containing (in mM) 150 NaCl, 2.5 KCl, 2.5 CaCl2, 1 MgCl2, 10 HEPES and 10 glucose, pH was 
adjusted to 7.4 with NaOH and osmolarity was adjusted to 340 mOsM with sucrose. Pipette 
solution contained (in mM) 100 N-methyl-D-glucamine, 100 CH3SO3H, 40 CsF, 10 MgCl2, 10 
HEPES and 5 EGTA, pH adjusted with CsOH to 7.4 and osmolarity to 290 - 300 mOsM with 
sucrose. 
 Brain slices were cut in high sucrose cutting solution containing 194 mM sucrose, 30 
mM NaCl, 4.5 mM KCl, 1 mM MgCl2, 26 mM NaHCO3, 1.2 mM NaH2PO4, and 10 mM glucose, 
bubbled with 95% O2, 5% CO2 prior to use. Hippocampal neurons were isolated in trituration buffer 
containing 20 mM NaCl, 130 mM N-methyl-D-glucamine, 2.5 mM KCl, 1 mM MgCl2, 10 mM 
HEPES and 10 mM glucose, osmolarity was adjusted with sucrose to 340 mOsM and pH was 
adjusted to 7.4 with HCl. 
 
4.4.2. Patch Clamp Electrophysiology of Isolated Neurons and HEK293 Cells (I, II, III) 
 
Patch clamp recordings were done from the cells adhering to the bottom of 35 mm culture dish, 
which was mounted in a recording chamber under the microscope. During the experiments the cells 
were continuously superfused with recording solution. Experiments were carried out at room 
temperature. Whole-cell (I, II, III) and outside-out (I) patch-clamp recording techniques were used 
(Hamill et al., 1981). Pipette resistance was 2 to 4 M?, when filled with an internal solution. Drugs 
and ethanol were diluted in recording solution and applied to whole cells with stepper motor driven 
solution application system (Warner Instrument, Hamden, CT). In the majority of experiments, 
neurons were lifted clear of the bottom of the culture dish to facilitate solution exchange. AMPA 
receptor agonists and drugs were applied simultaneously in most experiments. Solution exchange 
time of the drug application system was 150 ? 60 ms for isolated hippocampal neurons sitting in the 
bottom of the dish and 22 ? 5 ms for lifted cells, when measured by applying 1 mM kainate to the 
cells to activate the AMPARs and then changing the standard solution to the Na+ lacking solution, 
which almost completely eliminated the kainate-evoked current. 
 
4.4.3. Miniature EPSC Recordings from Hippocampal Slices (IV) 
 
Slice electrophysiology was done from CA1 pyramidal neurons of the hippocampus in 400 µm 
thick coronal slices. The brain slice containing the hippocampus was prepared as described above. 
After the cutting, the slices were transferred to the recording chamber under an upright Olympus 
BX51WI (Olympus Imaging Europa GmbH, Hamburg, Germany) microscope. The recording 
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solution was constantly flowing to the recording chamber at flow rate of 2 ml/min. Patch clamp 
electrode was 2-4 M? in resistance when filled with intracellular solution. Pyramidal neurons were 
identified on the basis of location in the dense CA1 pyramidal neuron layer and morphology. The 
miniature EPSC recordings were done with whole cell voltage clamp technique at the holding 
potential of -60 mV. In order to get enough miniature EPSCs the neurons were recorded at least for 
15 min at the presence of GABAA antagonist picrotoxin and NMDA antagonist APV. 
 
4.5. Maximal Electroshock (IV) 
 
Maximal electroshock (MES) convulsion test was done in study IV to find out the convulsion 
sensitivity of wild type and Thy1?6 mice. Electroshock-induced convulsions were produced by 
delivering rectangular unipolar positive current pulses (100 Hz, duration 1.0 sec; width 0.5 msec) 
via ear-clip electrodes from an ECT unit (Ugo Basile 7800, Comerio, Italy). Animals received a 
single electroshock (5-13 mA), after which they were observed for appearance of tonic hindlimb 
extension (THE) convulsion. The number of animals exhibiting THE was recorded and expressed as 
a percentage of the mice tested for each line and current intensity.  
 
4.6. Statistical Tests (I, II, III, IV) 
 
All statistical tests were done with Prism 3.0 software (GraphPad Software, Inc La Jolla, CA, USA) 
and SPSS 15.0.1 for Windows (SPSS Inc., Chicago, IL, USA). The analysis used to calculate 
statistical significances in the studies of the effect of ethanol was two-way ANOVA with post hoc 
comparisons using Bonferroni’s test (I) and repeated measures ANOVA (II). Miniature EPSCs (IV) 
were analysed with Kolmogorov-Smirnov test in Mini Analysis Program 6.0.3 (Synaptoft, Inc., 
Decatur, GA, USA). To determine the threshold for MES induced THE (IV), nonlinear regression 
fit with a sigmoidal four-parameter logistic equation in Prism software was used to determine the 
electroconvulsive threshold EC50 (current intensity sufficient to induce THE in 50% of animals). 
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5. Results and Discussion 
5.1 The Effect of Ethanol on AMPA Receptors 
5.1.1. Ethanol Inhibits AMPA Receptor fEPSPs 
 
Ethanol inhibited the fEPSP’s recorded from hippocampal slices from stratum radiatum 
(unpublished data). The inhibition was reproducible and reversible as depicted in Figure 7D. 
Interestingly, the inhibition was age dependent as there was a clear difference in ethanol inhibition 
when the animals were pooled into two groups, young mice (age under 1 month) and adult mice 
(age over 2 months) (Fig. 7 A,B). Ethanol did not affect paired pulse ratio of fEPSPs, which 
indicates that ethanol did not alter the release probability of glutamate (Fig.7C). In some recordings 
picrotoxin was present in bath solution to be sure that GABAA receptors were not contributing to 
observed ethanol inhibition. Picrotoxin application did not affect the extent of ethanol inhibition. 
 Aforementioned results were consistently seen in one laboratory during the whole 
period of experiments. However, we have not been able to repeat these findings in a different 
laboratory indicating that the phenomenon might be dependent on experimental conditions or the 
animal strain differences between the laboratories. Nevertheless, the results clearly show that also 
AMPA receptors along with NMDA receptors (Lovinger et al., 1990) can be very sensitive to 
ethanol in brain slice experiments. To date, we have not been able to clarify further what the exact 
conditions are, which make the AMPA receptors sensitive to ethanol in field potential recordings. 
 
5.1.2. Desensitization of AMPA Receptors Affects Ethanol Inhibition 
 
In patch clamp recordings from acutely isolated hippocampal neurons, cultured cortical neurons and 
HEK293 cells ethanol was found to inhibit AMPA receptor currents in a concentration-dependent 
manner. The receptor desensitization was found to affect the ethanol inhibition, as there was a 
correlation between receptor desensitization and ethanol inhibition (I). The correlation was shown 
with several different methods, which are summarized in Table 1. In summary, when high 
concentration of AMPA was used to activate currents in isolated hippocampal neurons, the steady 
state component of the current, which originate from receptor pool that contains mostly desensitized 
receptors, was inhibited more than the peak current, which originate from receptor pool containing 
mostly non-desensitized receptors. There was no difference in ethanol inhibition between the peak 
and steady-state current when low (10 µM) concentration of AMPA was used to activate currents, 
probably because under these conditions both the peak and the steady state current components 
originate from a receptor pool containing large amount of desensitized receptors. When kainate 
(which produces less desensitization than AMPA) was used to activate the currents, ethanol 
inhibition was decreased as compared to AMPA activated currents. However, ethanol inhibition of 
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Figure 7. Ethanol inhibits AMPA receptor mediated fEPSP’s in stratum radiatum of 
hippocampus. Ethanol inhibition of fEPSP amplitude in the presence of APV in young (age 
under 1 month) (A) and in adult mice (age over 2 months) (B). Ethanol did not affect 
paired pulse ratio of fEPSP amplitude of young mice (C). Representative traces of EPSP’s 
of young mice in the presence of 25-100 mM ethanol are shown in (D). Note that control 
and wash traces are overlapping. 
 
kainate activated current was found to depend on kainate concentration, as low concentration 
(30µM) activated currents were markedly more inhibited by ethanol; previously observed with 
oocyte expression system (Dildy-Mayfield and Harris, 1992). In addition, when cyclothiazide 
(which blocks the desensitization of AMPA receptors) was used together with AMPA, ethanol 
inhibition was decreased. Ethanol inhibition was also lower in GluR-A L497Y point-mutated 
homomeric receptors expressed in HEK293 cells as compared to wild type GluR-A. Finally, we 
used faster piezoelectric applicator and out-side-out membrane patches to better resolve the peak 
current of non-desensitized receptors, and found that it was not significantly inhibited by ethanol. In 
all experiments ethanol inhibition of AMPA currents was concentration-dependent, reproducible 
and reversible. In addition, ethanol inhibited the currents with or without 1 min pre-application of 
ethanol similarly suggesting that the effect of ethanol is very fast. 
 In order to measure ethanol effects on the rate of desensitization, the time course of 
the exponential decay of 100 µM AMPA-activated currents was determined using nonlinear curve 
fitting. Decay was well fitted with a single exponential function both in the absence and presence of 
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ethanol. The time constant (?) for decay of current during agonist exposure was similar in the 
presence and absence of ethanol (for 50 mM ethanol experiments, baseline = 42 ? 7 ms, ethanol = 
42 ? 7 ms; for 100 mM ethanol experiments, baseline = 35 ? 4 ms, ethanol = 33 ? 5 ms). 
 We also examined recovery from desensitization of 100 µM AMPA-induced current 
in the absence and presence of 100 mM ethanol in isolated hippocampal neurons (I; Fig. 5). This 
was accomplished using a two-pulse protocol in which AMPA was applied for 100 ms followed by 
a wash period of 200 to 1000 ms, and subsequent reapplication of AMPA. ethanol was applied 
throughout the duration of the recording. The peak amplitude of AMPA-induced current recovered 
with a time constant of 189 ms (95% confidence interval 175–204 ms, n = 9 cells) and this value 
increased to 233 ms (95% confidence interval 217–250 ms, n = 9 cells) in the presence of ethanol. 
Thus, ethanol produced a modest slowing of the rate of recovery from desensitization, which 
indicates that ethanol keeps the receptors in a desensitized state for a longer time than in control 
situation. 
 
Table 1. Ethanol inhibition of AMPA receptors depends on desensitization (I) EtOH = 
ethanol; Ethanol inhibition % (inh. %) was calculated comparing current ampliture of 
ethanol application to the average of current amplitude of control applications before and 
after the given ethanol application. The bolded text in comment column is a conclusion 
made from the results supported with statistical significance. 
 
Current activation 
condition 
EtOH inh. % 
50 mM 
EtOH inh. % 
100 mM 
Comment / Conclusion 
10 µM AMPA IPEAK 21 36 EtOH inhibition is not different between 
10 µM AMPA ISS 22 36 10µM AMPA activated peak and SS current 
100 µM AMPA IPEAK 7 16 EtOH inhibits peak less than SS current. 
100 µM AMPA ISS 21 37 ? Desensitized receptors inhibited more 
by ethanol. 
30 µM kainate 34 44 Low concentration of kainate activated 
currents are highly sensitive to EtOH. 
1 mM kainate 12 23 High concentration of kainate activated 
currents are less inhibited by EtOH as 
compared to AMPA activated currents. ? 
Non-desensitized receptors less inhibited. 
10 µM AMPA 21 39 cyclothiazide decreases EtOH inhibition 
+ cyclothiazide (same cells) 12 19 ? Inhibition of desensitization decreases 
EtOH inhibition. 
HEK cells: GluR-Ai WT 26 46 less EtOH inhibition with non- 
                  GluR-Ai L497Y 5 19 desensitizing mutant receptor 
ultrafast appl. 100 µM IPEAK  0 Pure peak current is not inhibited by EtOH. 
                                     ISS   40 ? EtOH does not inhibit non-
desensitized AMPA receptors 
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5.1.3 Ethanol Accelerates the Desensitization of GluR-Di Receptors Coexpressed with TARPs 
in HEK293-cells 
 
To study the effects of TARPs on AMPA receptor currents, a saturating concentration of glutamate 
(10 mM) was applied for 1 s to the HEK293 cells expressing GluR-Di receptors. Coexpression of 
TARPs increased steady-state current/peak current-ratio, slowed the 10 to 90 % rise time of the 
peak current slightly and slowed the onset of the desensitization, measured as ?-value of decay of 
the peak current (II; Fig. 1). 
Ethanol inhibited the recombinantly expressed GluR-Di AMPA receptor currents, 
either with or without coexpressed TARPs, in a concentration-dependent manner. The steady-state 
current was inhibited more than the peak current (II; Fig. 2) 
 Ethanol decreased the ?-value of desensitization in GluR-Di receptors (II; Fig. 3). The 
coexpression of either stargazin or ?4, further increased the effect of ethanol on desensitization. The 
highest ethanol concentration tested, 200 mM, reduced the ?-value by 16.5 ± 4.9 % (n=5) in GluR-
D flip receptors, and by 29.3 ± 9.3 % (n=6) in GluR-Di with stargazin. With ?4 coexpression 200 
mM ethanol reduced the ?-value by 34.2 ± 5.0 % (n=7) and in the matching control experiments 
with Di by 14.4 ± 5.8 % (n=5).  
 Next, we measured the effect of ethanol on the recovery from desensitization of GluR-
Di receptors expressed with or without TARPs. Coexpression of stargazin did not affect the time 
constant of recovery from desensitization, ?rec, but coexpression of ?4 increased it. 100 mM ethanol 
did not affect the ?rec. The results differ from the results of study I where 100 mM ethanol was 
found to increase the time of recovery from desensitization in isolated hippocampal neurons. ?rec-
values between the studies also varied substantially, being 189 ms in neurons (I), and 31 ms for 
GluR-Di expressed in HEK-cells (II). This difference might reflect the different AMPA- and TARP-
subunit composition between the studies. TARPs seem to affect the time of recovery from 
desensitization, since we observed that the coexpression of ?4 increased the ?rec to 59 ms (II). 
 
5.1.4. General Discussion of Ethanol Inhibition of AMPA Receptors 
 
Studies on the inhibition of AMPA receptors by ethanol have produced controversial results. 
Studies in brain slices, where the neurotransmission is intact, have produced to date mainly data 
showing that ethanol does not inhibit AMPA receptor-mediated function (Carta et al., 2003; 
Hendricson et al., 2003; Lovinger et al., 1989; Lovinger et al., 1990; Weiner et al., 1999), rare 
exceptions being neonatal CA3 area of the hippocampus (Mameli et al., 2005) and central amygdala 
(Zhu et al., 2007). On the other hand, numerous studies done with isolated neurons or heterologous 
expression systems, like Xenopus laevis oocytes or HEK293 cells, have shown that AMPA 
receptors are sensitive to ethanol at clinically relevant concentrations (Dildy-Mayfield and Harris, 
1992; Lovinger, 1993; Wirkner et al., 2000). In these experiments, AMPA receptors have been 
found to be inhibited by ethanol as much as NMDA receptors, which are, along with GABAA 
receptors, considered to be the most important targets of ethanol in the brain. Our data give a 
possible explanation to this discrepancy as ethanol mainly affects desensitized AMPA receptors (I). 
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The extent of receptor desensitization differs radically between brain slice experiments and cell 
experiments, because synaptic AMPA receptor currents are thought to originate from non-
desensitized channel openings, whereas in experiments with isolated or cultured cells the receptor 
currents are evoked by applying agonist onto the cells for such a long time that the currents 
originate from the receptor pool containing mostly desensitized receptors. In cell experiments, 
currents originating from non-desensitized receptors can be activated only if high enough 
concentration of agonist is applied to the receptors, faster than the onset of desensitization. We did 
this using piezoelectric applicator and outside-out membrane patches pulled from cultured cortical 
neurons, and showed that the pure peak current is not significantly inhibited by ethanol. 
 Interestingly, our results show that ethanol decreases the ?-value of desensitization of 
GluR-Di receptors expressed in HEK293 cells. When either stargazin or ?4 are coexpressed with the 
GluR-Di, this effect of ethanol on desensitization is enhanced (II). Our data suggest that ethanol 
inhibits AMPA receptors by speeding up the transition to desensitized state. The involvement of 
TARPs in ethanol inhibition of AMPA receptors may be significant in the brain where putatively 
the majority of AMPA receptors are combined with TARPs in synapses (Hashimoto et al., 1999; 
Menuz et al., 2008; Milstein et al., 2007; Rouach et al., 2005; Tomita et al., 2003). GluR-Di which 
we used in HEK293-cell expression studies is strongly expressed during development (Gallo et al., 
1992; Mosbacher et al., 1994; Zhu et al., 2000), as is the ?4 subunit of TARPs, which is the only 
TARP expressed during development (Tomita et al., 2003). Ethanol was found to speed up very 
efficiently the transition to desensitized state of GluR-Di??4 combination, which might increase the 
sensitivity of developing nervous system to ethanol. Our fEPSP recordings from hippocampal slices 
of young animals also suggest that AMPA receptor-mediated synaptic function is sensitive to 
ethanol. Therefore, AMPA receptors in developing brain might be sensitive to ethanol in some 
conditions. Inhibition of AMPA receptors by ethanol could thus contribute to the impairments 
induced by fetal alcohol exposure, e.g. in fetal alcohol syndrome (Calhoun and Warren, 2007). 
 As discussed above, ethanol has been shown to inhibit AMPA receptor currents in 
native synaptic conditions only rarely (Mameli et al., 2005; Zhu et al., 2007). This might be 
because, generally speaking, the desensitization does not participate in synaptic AMPA receptor 
currents. Miniature EPSCs and currents activated by electrical stimulation decay at the rate of 
deactivation, rather than at the rate of desensitization. However, there are brain areas where the 
desensitization has been shown to participate in synaptic AMPA receptor currents, such as in 
cerebellum and at a calyceal synapse (Barbour et al., 1994; Maguire, 1999; Otis et al., 1996; 
Trussell et al., 1993; Wall et al., 2002). In these brain areas, clinically relevant concentrations of 
ethanol might inhibit the AMPA receptors. The lowest concentration affecting AMPA receptors in 
electrophysiological studies is around 20 mM, which is equivalent to 1 per mille of blood alcohol, 
achievable during moderate drinking. Some of the effects of high ethanol intoxication, like loss of 
memory and motor coordination problems could well be caused by the effect of ethanol on AMPA 
receptors along with NMDA receptors.  
 Our studies on ethanol inhibition of AMPA receptors were carried out in acutely 
isolated native neurons (I) and HEK293 cell expression system (II). The results between the studies 
were generally similar, albeit with some minor differences. The peak current was inhibited less than 
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steady-state current in both studies, and the extent of ethanol inhibition of these currents was similar 
between the studies. However, in native hippocampal neurons ethanol did not affect the rate of 
desensitization, whereas in HEK293 cells it did. The other difference was that ethanol increased the 
recovery from desensitization in native neurons, but not in HEK293 cells. One possible explanation 
for these discrepancies is different combinations of AMPA and TARP subunit expression between 
the experimental preparations. Hippocampal neurons express extensively ?8 and also smaller 
amounts of other TARPs (Tomita et al., 2003) and GluR-A, -B and -C subunits of AMPA receptors 
(Keinänen et al., 1990). The other major difference between native neurons and expression systems 
is that the receptors are differently regulated by other proteins. For instance, in acutely isolated 
neurons part of the receptors are still attached to the postsynaptic density protein complex, whereas 
in HEK293 cells they are on the cell membrane in non-organized manner. 
 
5.2. Agonist Binding Capability Determines AMPA Receptor Trafficking 
 
In order to study the trafficking of AMPA receptor from the ER, point mutated GluR-Di receptors 
were expressed in HEK293 and COS7 cells and the surface expression of them was measured using 
electrophysiology, immunofluoresence and surface biotinlation assay. Receptors used in this study 
were: GluR-Di R507K and E727Q, which do not bind glutamate (Jouppila et al., 2002); E727D, 
which preserves binding although with somewhat lowered affinity for glutamate; and L505Y, which 
does not desensitize to the same extent as the wild type counterpart but retains binding. 
 To verify the functional status of the mutant receptors, whole cell patch clamp 
recordings were made from transfected HEK293 cells. L-Glutamate (10 mM) elicited rapidly 
desensitizing currents in both wild-type and E727D receptor channels, whereas no measurable 
current was observer with R507K or E727Q mutants. A substantial non-desensitizing steady-state 
current was observed with the E727D mutant but not with WT GluR-Di (III; Fig 2A). Glutamate 
triggered a robust non-desensitizing current in GluR-D L505Y receptors. EC50-values for glutamate 
and AMPA were calculated from dose response curves and are reported in Table 2. 
 Next, we wanted to know the expression levels of AMPA receptors and what state of 
the trafficking process the receptors undergo using immunofluorescence microscopy, 
endoglycosidase H (EndoH) treatment and LBD-secretion analysis. The results are presented in 
Table 2. In summary, the overall protein expression levels did not differ between the GluR-Di 
receptors indicating that the cells translate all the cDNAs to proteins and that the cells are not 
degrading any mutant receptor faster. Only WT GluR-Di and E727D mutant showed intense surface 
binding indicating that they are transported to cell surface in large quantities. L505Y staining was 
lower than with wild type GluR-Di, even thought in patch clamp recordings with this mutant 
receptor had large currents of hundreds of pA which is comparable to wild type GluR-Di currents 
(III: Fig. 2A). The possible reason for this discrepancy is that non-desensitizing receptors produce 
large currents even when their number is low on the cell surface. Interestingly, inclusion of 
competitive antagonist NBQX increased the surface expression dramatically (III: Fig. 3C). The 
reason for this may be that the antagonist function as molecular chaperone which facilitate the 
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trafficking of receptor or that it was able to prevent the possible cell toxicity that might result from 
expression of non-desensiting mutant. R507K and E727Q mutant receptors were largely absent 
from cell surface. E727Q, R507K and L505Y were sensitive to EndoH-treatment, which indicates 
that they contained unprocessed glycans that are added in ER, but have not been processed further 
in Golgi apparatus. Therefore, the receptor mutants are primarily retained in the ER. Immunoblot 
analysis of media and cell extracts of transfected HEK293 cells revealed S1S2-LBD of GluR-Di and 
E727D mutant were efficiently secreted into the culture medium indicating that LBD is translated 
and trafficked independently of other domains of AMPA receptors. LBD of L505Y mutant was 
secreted at intermediate level, whereas all nonbinding mutant LBDs were not secreted. 
Interestingly, the coexpression of stargazin was able to rescue the surface expression of nonbinding 
R507K and E727Q receptors. 
 
Table 2. Summary of the results of Wild type GluR-Di and point mutated receptors. + = 
strong; +/- = intermediate/detectable; - = not detectable; EndoH = endoglycosidase H 
enzyme (endoglycosidase H cleaves the glycans which have been added in the ER, but 
not if processed further in the Golgi apparatus. Resistance to EndoH thus reveals if the 
proteins have been trafficked out from the ER.); Perm. im.staining = permealized 
immunostaining; non-perm im.staining = non-permealized immunostaining.  LBD = ligand 
binding domain (Cell lines secrete constructed S1-S2-ligand binding domains to the cell 
culture media. The corresponding point mutations that were in full length receptors were 
made to LBD). 
 
construct phenotype Glutamate 
EC50 
AMPA 
EC50 
perm. 
im.staining 
non- 
perm. 
im.staining 
resist. 
to 
EndoH 
LBD 
secretion 
Di (WT) 
 
Wild type 2 mM 86 µM + + + + 
R505K 
 
non binding for 
AMPA and Glu 
- - + - - - 
E707Q 
 
non binding for 
AMPA and Glu 
- - + - - - 
E727D lower affinity to 
Glu 
64 mM 100 µM + + + + 
L505Y non-desensitizing 49 µM 30 µM + +/- - +/- 
 
 Next, we investigated how point mutated AMPA receptors are trafficked in neurons, 
which natively express GluR-D and other AMPA receptor subunits, as well TARPs. For this 
purpose, the cortical neurons were co-transfected with GFP and GluR-D cDNAs at 10 d.i.v. and 
visualized for GFP expression and anti-Flag surface staining at 14 d.i.v. Clear surface labeling was 
seen for recombinant GluR-Di and GluR-Do receptors. In contrast, the nonbinding GluR-Di mutants 
R507K and E727Q, which were not trafficked to the cell membrane in cell lines (in the absence of 
stargazin), did not show any surface expression in transfected neurons. As cortical neurons express 
stargazin and other TARPs (Tomita et al., 2003), the specific trafficking defect observed for the 
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non-binding GluR-D mutants implies differences in the quality control mechanisms and regulation 
of trafficking between neurons and heterologous cells. 
The results show that agonist binding capability is an important determinant of 
whether ER quality control will allow AMPA receptors trafficking to cell membrane. Quality 
control checking is independent of other domains and tetrameric structure of the receptor, since the 
extracellular secretion of S1S2-LBD is regulated similarly to the full length receptors surface 
expression. Our results confirm further the influence of stargazin (or other TARPs) in the 
trafficking of AMPA receptors because its coexpression rescued the non-glutamate-binding 
mutants. However, in neuronal cultures AMPA receptors, which are unable to bind glutamate, do 
not enter the cell surface, although the neurons express endogenous TARPs, including stargazin. 
The trafficking machinery between expression cell lines and cultured neurons differs in this respect, 
being apparently more complex and selective in neurons. This indicates that still unknown proteins 
or protein modifications could participate in AMPA receptor quality control in mature neurons. The 
role of TARPs in the control of AMPA receptor trafficking may increase during the development. 
Neurons seem to express more flop-isoforms of AMPA receptors as the nervous system matures 
(Gallo et al., 1992; Mosbacher et al., 1994), and particularly the flop forms seem to require the 
assistance of TARPs in trafficking to the cell membrane (Coleman et al., 2006; Penn et al., 2008). 
Desensitization (or the ability of the receptor to transition between non-desensitized 
and desensitized state) has also been proposed to have a role in trafficking of AMPA receptors 
through ER (Fleck, 2006). The non-desensitizing GluR-B mutant (L504Y) is expressed poorly on 
surface of neurons, whereas a mutant (N768D) with accelerated desensitization has increased 
surface expression (Greger and Esteban, 2007; Greger et al., 2006). Also in kainate receptors, 
desensitization plays a role in receptor trafficking as mutant GluR6 receptors locked in a non-
desensitizing conformation are poorly transported to cell surface (Priel et al., 2006). Consistent with 
these studies, we found that the non-desensitizing GluR-Di mutant L505Y has reduced cell surface 
expression as compared to wild type receptor (III: Fig. 3C). However, in our study, the inclusion of 
NBQX increased the surface expression of L505Y receptor, and improved the condition of cultured 
cells indicating that expression of L505Y is toxic to the cells. Part of the observed decrease in the 
surface expression might, therefore, be result of the death of the cells expressing high levels of this 
particular mutant. 
 
5.3. Maximal Electroshock Sensitivity and Synaptic AMPA Receptor Function Are Decreased 
in Thy1?6 Mice 
 
To determine the electroconvulsive sensitivity of Thy1?6 and wild-type mice, they were 
subjected to electroshocks of different intensities. The occurrence of tetanic hind limb extension 
(THE) was observed. When the proportion of animals having THE was plotted as a function of 
current, electroconvulsive threshold EC50 of the wild-type mice was 8.2 mA (R2 = 0.9618; 95% 
confidence interval 7.9 - 8.6), which was about 2 mA (P < 0.001) lower than the EC50 of Thy1?6 
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mice (10.0 mA; R2 = 0.9548; 95% confidence interval 9.7 - 10.4). Thus, the transgenic mice 
displayed a higher threshold to electroconvulsions. 
In order to find the explanation for the observed differences in electroshock thresholds the 
state of AMPA receptor-mediated excitation was studied using mEPSC recordings of hippocampal 
CA1 pyramidal neurons. When the individual mEPSCs from the complete recording of WT and 
Thy1?6 mice were averaged, and the traces reproduced, there was a difference in the peak 
amplitude with the shapes remaining identical (IV; Fig. 2). The wild-type mice had significantly 
higher average amplitude of 10.3 ? 2.5 pA (mean ? SD, n=13) as compared to that of Thy1?6 mice, 
which was 8.4 ? 2.2 pA (n = 16; P < 0.05, Student’s t-test). This can also be seen in a relative 
cumulative frequency histogram-plot (IV; Fig. 2B). AMPA receptor mEPSCs from wild-type and 
Thy1?6 mice had a similar frequency (0.25 ? 0.19 Hz and 0.20 ? 0.22 Hz, respectively) and ?-value 
of decay (4.7 ? 1.8 and 4.7 ? 2.5, respectively). 
In Thy1?6 mice the overexpression of GABAA receptor ?6 subunit is induced in various 
forebrain areas including CA1 area of the hippocampus. In this brain region the overexpression of 
?6 subunit leads to a five-fold increase of extrasynaptic GABAA receptor-mediated tonic inhibition 
(Wisden et al., 2002). There is also 30 % less synaptic GABAA receptor-mediated inhibition as 
measured by mIPSC analysis (Wisden et al., 2002), probably because overexpression of ?6 diverts 
GABAA receptor subunits to an extrasynaptic location from synaptic location. Interestingly, our 
results also show that synaptic AMPA receptor function is decreased in these animals. This suggests 
that synaptic scaling processes reduce the synaptic excitation as a response to decreased synaptic 
inhibition. The difference in electroshock sensitivity between Thy1?6 mice and wild types could be 
due to decreased AMPA receptor function, as AMPA receptor blockers are also reported to 
decrease MES induced convulsions (Micale et al., 2002; Yamashita et al., 2004). The other 
explanation for decreased MES sensitivity in Thy1?6 mice may be the increased extrasynaptic 
inhibition. However, this seems unlikely. Thy1?6 mice are more sensitive to GABAA receptor 
antagonists, picrotoxinin and DMCM-induced convulsions (Sinkkonen et al., 2004) indicating that 
phasic inhibition is more important in resistance to convulsions than tonic extrasynaptic inhibition. 
DMCM antagonises mainly synaptic GABAA receptors (Knoflach et al., 1996), and might even 
have a positive effect on extrasynaptic GABAA receptors in Thy1?6 mice (Crestani et al., 2002). 
 We observed that only the amplitude of mEPSCs was decreased in Thy1?6 mice, the 
frequency and time constant of decay being at the same level as in wild types (IV). This indicates 
that there are changes in AMPA receptors at the post synaptic membrane, such as decrease in 
number, change in phosphorylation or subunit composition. It has been shown that phophorylation 
increases the opening frequency and the mean open time of AMPA receptors (Greengard et al., 
1991). Decay kinetics of AMPA receptor currents has also been shown to depend also on subunit 
composition of AMPA receptors (Geiger et al., 1995). Since the time constant of mEPSC decay did 
not differ between the mouse lines in study IV, AMPA receptor populations presumably had the 
same subunit composition. This implies that the number of receptors in synapses was lower in 
Thy1?6 mice. The removal of AMPA receptors from synapses is a dynamic process involving 
complex interaction between many proteins. For instance, in cerebellar Purkinje cell LTD GluR-B 
containing receptors are taken out from synapses through protein kinase C phosphorylation of 
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ser859 in intracellular C-tail of GluR-B (Chung et al., 2000; Matsuda et al., 1999). This leads to a 
decrease of AMPA receptor binding to GRIP and actin-binding proteins, but increases the binding 
to PICK1, which promotes the removal of AMPA receptors from synapses. Phosphorylation of 
ser859 has been shown to increase the removal of AMPA receptors from synapses in hippocampus 
(Chung et al., 2000; Perez et al., 2001); albeit the phosphorylation is not executed by PKC, but by 
some still unknown kinase (Kim et al., 2001). Recent studies have discovered one possible 
intracellular signalling mechanism in regulation of number of AMPA receptors on neural 
membrane; immediate early gene Arc (Shepherd et al., 2006). High neural activity increases the 
levels of Arc protein, which leads to the endocytosis of AMPA receptors, causing a decrease in 
AMPA receptor surface expression and thus a decrease in AMPA receptor mEPSC. In contrast, low 
neural activity decreases Arc levels and increases AMPA receptor surface expression and mEPSC 
amplitude. However, the role of Arc in the regulation of synaptic AMPA receptors is not as 
straightforward as mentioned above, because Arc is also induced in LTP consolidation, which 
requires net insertion of AMPA receptors (Guzowski et al., 2000). 
 
5.4 Future Directions in the Research of AMPA Receptors 
 
 In this thesis (study I, II) it was shown that ethanol inhibits AMPA receptors and the 
mechanism of inhibition was found to be the increase of desensitization of the receptor. It is still 
unclear in what conditions AMPA receptors participate in the actions of ethanol in the brain. Our 
fEPSP recordings showed that in young mice AMPA-mediated synaptic function can be sensitive to 
ethanol. However, it has not been widely reported that AMPA receptors are markedly inhibited by 
ethanol in intact synaptic transmission. Therefore, more studies in this field are required. These 
experiments should target the brain areas where desensitization participates in synaptic AMPA 
currents like cerebellum (Barbour et al., 1994; Wall et al., 2002). The effect of ethanol on synaptic 
AMPA function should also be studied in different conditions. For instance, train stimulation of 
axons could elevate the extracellular glutamate concentrations and lead to the situation where 
AMPA receptors would be partially desensitized and thus sensitive to ethanol. This would mimic 
the burst firing of neurons (Swensen and Bean, 2003) and hyperexcitability related to brain 
pathology (Chattipakorn and McMahon, 2003). The effect of TARPs on ethanol inhibition of other 
GluR subunits than GluR-D should to be studied also in order to clarify the exact role of TARPs in 
the effects of ethanol. Whether TARPS play a role in some of the rare instances where ethanol 
inhibits AMPA receptors (Mameli et al., 2005; Zhu et al., 2007) should also be clarified. 
 Studies of AMPA receptors have increased our understanding of how the brain works. 
The control of AMPA receptor function and trafficking are now considered one of the most 
important mechanisms in many aspects of brain function, such as learning and memory, as well as 
brain pathology. In recent years, many proteins involved in various stages of AMPA receptor 
trafficking and regulation of function have been discovered. Great deal of advances has also been 
made in determining the important domains and amino acids in the AMPA receptors involved in 
protein interactions. However, there are still many unknown proteins and regulation mechanisms in 
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AMPA receptor trafficking. For example, the known protein interactions do not sufficiently explain 
all the mechanisms of quality control taking place in ER and how the insertion and removal of 
synaptic AMPA receptors is regulated. Our results (III) indicate that glutamate binding capability is 
an important feature of GluR-D receptors in trafficking out of ER. Is the glutamate binding also 
important in the trafficking of other GluR subunits? In study III the non-desensitizing mutant 
receptor was trafficked to cell membrane less efficiently than wild type receptors. Does this also 
relate to agonist binding capability, since desensitized receptors bind glutamate with highest 
affinity? 
One fundamental weakness in many of the studies on regulation of AMPA receptor 
trafficking and function has been that they make use of heterologous expression cell lines instead of 
native conditions. The regulation of AMPA receptors may differ substantially between these two 
conditions, as became evident in study III where the surface expression of non-binding mutants was 
rescued by stargazin in HEK293 cells but not in cultured neurons. AMPA receptor regulation is 
very complex and may require many proteins that are not present in expression cell lines. In 
addition, the difference in morphology between dendritic tree containing neurons and more-or-less 
round and flat shape expression cells may contribute to the differences in experimental conditions 
and results. As the research methods develop in future, research should concentrate more on studies 
in native conditions in order to clarify how brain function is really regulated. This is especially 
important if we wish to find treatments to pathological conditions involving AMPA receptors. 
Knowing the exact molecular regulation mechanisms would not only help to develop new medical 
treatments, but also help to explain possible adverse effects and weaknesses in them. For instance, 
from the study IV and studies with AMPA antagonists (Micale et al., 2002; Yamashita et al., 2004) 
one can conclude that reducing AMPA receptor function could be used as an anticonvulsion 
treatment. Whilst this approach could work in some types of acute convulsions, it would probably 
not be a good strategy for a long term medical treatment, such as convulsion prevention, since 
synaptic scaling would likely increase the excitation back to the level it use to be before the 
treatment. 
 
Conclusions 
________________________________________________________________________________________________________________________ 
58 
6. Conclusions 
 
1. Ethanol inhibition of AMPA receptors depends heavily on the receptor desensitization. The 
more receptors that are desensitized the higher is the ethanol inhibition. Ethanol speeds up 
the rate of desensitization of GluR-Di receptors expressed in HEK293-cells. 
 
2. When TARPs are coexpressed with GluR-Di, increase in the rate of desensitization by 
ethanol is greater than with GluR-Di alone. Accelerating the rate of desensitization is a 
mechanism of ethanol inhibition of AMPA receptors which leads to an increase in the time 
the receptors channel spend in closed state. 
 
3. Ligand binding capability is important determinants of the early trafficking of GluR-Di 
AMPA receptors. Desensitization plays a minor role in it. The TARP stargazin is able to 
rescue the trafficking to the cell surface of non-ligand binding receptors in expression cell 
lines, but endogenous TARPs fails to do so in primary neuronal cultures.  
 
4. Hippocampal synaptic function of AMPA receptors is decreased in a transgenic mouse line 
which has less synaptic GABAA receptor-mediated inhibition. This mouse line is also less 
sensitive to electrical convulsions. The results demonstrate that synaptic excitatory and 
inhibitory neurotransmission systems tend to be in balance. 
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